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ABSTRACT 
Perceived racial discrimination (PRD), perceived gender discrimination (PGD), 
and discrimination-related stress (DS) have been shown to predict poor health and 
substance abuse in African-American women. They may contribute to racial disparities in 
both HIV infection and incarceration, which disproportionately affect African-American 
women. Critical consciousness (CC), the awareness of sociopolitical inequality, may 
provide a buffer against the effects of discrimination on health outcomes. This study 
examined (1) the effects ofPGD, PRD, and DS on health and substance use and of CC as 
a moderator of these relationships in HIV-infected African-American women; and (2) the 
relationships ofPRD, PGD, DS, and CC to HIV status and incarceration in HIV-infected 
and uninfected women. Seventy-three HIV -infected and 25 HIV -uninfected African-
American women (ages 26 to 72 years) from the Chicago site of the Women's 
Interagency HIV Study completed self-report measures ofPGD, PRD, DS, CC, 
depressive symptoms, quality oflife, cigarette smoking, anti-retroviral medication 
adherence and substance use. Blood pressure, body mass index, cholesterol, CD4+ cell 
count, and HIV viral load were also measured. 
Multiple linear and logistic regressions revealed that in HIV -infected women, 
v 
PRD significantly related to higher and PGD related to lower blood pressure, likelihood 
of cigarette smoking, and likelihood of crack/cocaine/heroin and marijuana use. PRD 
significantly related to lower viral load when controlling forDS. Path analyses showed a 
significant direct relation of PRD to lower depressive symptoms, but a significant indirect 
relation to higher depressive symptoms as mediated by DS. Critical consciousness was 
found to relate to better HIV health markers in the context of high discrimination. At 
higher PGD, PRD, and DS, women with higher CC had higher CD4+ counts and lower 
viral load than women with lower CC. Partial correlations showed that in HIV -infected 
and uninfected women, there were significant positive relations of incarceration to PGD, 
PRD, DS, and CC. These results suggest that relationships ofPGD, PRD and DS with 
health and substance use are complex, being protective for some outcomes but conferring 
risk for others. CC related to better health outcomes and provided a buffer against poor 
HIV health at high levels of discrimination. 
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CHAPTER ONE 
Introduction 
The most dramatic increase in the human immunodeficiency vims/acquired 
immunodeficiency syndrome (HIV I AIDS) epidemic in the past decade has been among 
low-income, non-Hispanic, African-American women. African-American women are 
more likely to contract and die from HIV than women from other ethnic groups. They are 
at greater risk for coronary heart disease (CHD) mortality in comparison with White 
women (Gillum, 1991; Centers for Disease Control and Prevention [CDC], 2005; 2007; 
2008) and are less likely to initiate and adhere to HIV medication regimens (Berget al., 
2004; Cohen et al. , 2002). Chronic stress related to perceived racial (PRD) and gender 
discrimination (PGD), defined as interpersonal and institutional manifestations of social 
power imbalances in the context of racism and sexism, is relevant to the everyday 
experiences of African Americans and may play a key role in these health disparities. In a 
study utilizing focus groups, African Canadian women indicated that sexism and racism 
were two of the most significant socio-cultural factors contributing to HIV risk 
(Newman, Williams, Massaquoi, Brown, & Logie, 2008). However, perceived racial and 
gender discrimination have not yet been systematically examined in relation to HIV-
related health. 
Some types of coping have been found to moderate the effects of stress on health. 
There is some evidence of a relationship between the use of avoidance and denial and 
lower anti-retroviral (ART) adherence in HIV-positive individuals (Moskowitz, Hult, 
Bussolari, & Acree, 2009). Paulo Freire (1970) defined the critical consciousness (CC) as 
2 
the awareness of structural inequality that motivates individuals from oppressed groups to 
work toward social change. Thus, CC can be conceptualized as an approach-oriented 
coping strategy that may address inequitable social conditions that foster racial disparities 
in HIV -related and general health, discrimination, unemployment, and incarceration 
(Bowleg, Teti, Malebranche, & Tschann, 2012), in contrast to coping by denying these 
issues. CC may be protective against poorer health outcomes when experiencing racial 
and gender discrimination by externalizing the cause of the unfair treatment to systemic 
inequalities or blaming the system, rather than attributing cause to personal failure, or 
blaming oneself. Moreover, one of main components of and goals of CC is mobilization 
for social change (Freire, 1973). Awareness of the social inequality based on social group 
membership not only allows for externalized attributions of discrimination but can 
empower individuals to take action toward more just individual and social outcomes. 
The current study systematically investigated the relationships between CC and 
HIV -related health behaviors and outcomes, as well as substance use in low-income, 
African-American women with HIV and at risk for HIV. In particular, CC was examined 
as a moderator of the effects ofPRD, PGD, and DS on health behaviors and outcomes. 
The associations ofPRD, PGD, and DS with HIV-related health behaviors and outcomes 
and substance use were also investigated. 
The HIV Epidemic: Low-Income African-American Women 
Although HIV/AIDS mortality rates have steadily decreased since the 
introduction ofhighly active antiretroviral therapy (HAART), a drug treatment that 
effectively slows disease progression and increases life expectancy (CDC, 2008; Levine 
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et al., 2007), HIV infection and mortality rates persist in African American communities, 
particularly among women. African-American women had one of the highest rates of 
HIV infection incidence in 2006, second only to African-American men, comprising 35% 
of new HIV diagnoses among African Americans. African-American women had the 
highest incidence rate among all women, at 65% of new infections (CDC, 2008). The 
racial disparity in new HIV infections was more pronounced in women than in men. 
African-American women were 15 times more likely to contract HIV than White women 
and almost 4 times more likely than Hispanic women. These ratios are in contrast with 
the racial disparities in infection in men. African-American men were 6 times more likely 
than White men, and 3 times more likely than Hispanic men, to contract HIV (CDC, 
2008). African-American women were 22 times more likely than White women to 
receive an AIDS diagnosis, accounting for 60% of women diagnosed with AIDS in 2007. 
AIDS is one of the leading causes of death of African-American women ages 25 to 44 
(CDC, 2005). 
These racial and gender HIV health disparities urgently call for a systematic 
investigation of the processes and structural factors that create conditions to support and 
perpetuate them (Newman, Williams, Massaquoi, Brown, & Logie, 2008). PGD and PRD 
are especially relevant to the lives of African-American women. As chronic stressors, 
they may contribute directly to alcohol and substance use, psychological problems such 
as depression and lower quality of life, and increased cardiovascular risk. Some of these 
effects (e.g., substance abuse) increase the risk ofHIV infection, and all are associated 
with lower adherence to antiretroviral therapy (ART), faster disease progression and 
ultimately, to HIV/AIDS-related mortality (Cohen et al., 2002). The effects of the 
specific stressors of racial and gender discrimination may explain some of the HIV-
related health disparities in African-American women relative to women of other 
racial/ethnic groups. These stressors have not yet been systematically explored in 
African-American women with HIV. 
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HIV Disease Markers and ART Adherence. The primary method to inhibit HIV 
disease progression and increase life expectancy is strict adherence to ART. Non-
adherence to ART is associated with virological failure and increased mortality rates 
(Nieuwkerk & Oort, 2005; Schackman et al., 2007). African-American women are less 
likely than White women to initiate ART medication when it is indicated (Cohen et al., 
2004). Chronic stress, depression, alcohol dependence, and illicit drug use have all been 
shown to contribute to decreased ART adherence in women (Applebaum, Richardson, 
Brady, Brief, & Keane, 2009; Cook et al., 2006; Turner, Laine, Cosier, & Hauck, 2003). 
Findings from a longitudinal study on cumulative general stress (e.g., daily parenting 
stress, acute stress from negative life events) showed that in HIV-infected mothers, 
higher cumulative stress related to both lower ART adherence and more missed medical 
appointments (Mellins, Kang, Leu, Havens, & Chesney, 2003). A body of literature 
demonstrates the relationships between PRD and PGD and psychological distress, 
depressive symptoms, and substance abuse. Thus the effects of experiences of both PRD 
and PGD may indirectly decrease ART adherence and thus increase HIV disease 
progression as mediated by stress, depressive symptoms, and substance use. 
HIV, Depressive Symptoms, and Quality of Life 
5 
HIV infection is associated with high rates of depression, with rates twice as high 
in HIV-infected individuals compared with HIV-uninfected counterparts (Ciesla & 
Roberts, 2001). The rate of depression in HIV-infected women is 4 times greater than in 
HIV -uninfected women (Morrison et al., 2002). Depressive symptoms are also high in 
persons newly diagnosed with HIV (67%), with higher likelihood of depression in newly-
diagnosed women compared to men (Bhatia, Hartman, Kallen, Graham, & Giordano, 
2010). Higher depressive symptoms in this sample were associated with low-income, 
recent substance abuse, poor access to medical care, low self-efficacy, lower CD4+ cell 
count, and detectable viral load. In an 84% male and 44% African American sample of 
people with HIV, depression predicted detectable viral load, lower CD4 cell count, and 
lower ART adherence (Boarts, Sledjeski, Bogart, & Delahanty, 2006). Higher depressive 
symptoms predicted increased physical symptom severity during later stages ofHIV and 
AIDs-related mortality, even after accounting for medication adherence, substance abuse, 
and demographic factors (Cook et al., 2004). Chronic depressive symptoms in women 
with and at risk for HIV were found to relate to higher cardiovascular risk (Schwartz et 
al., 2012). Post-traumatic stress disorder (PTSD) and depressive symptoms predict higher 
viral load and lower CD4 cell count (Boarts et al., 2006). 
HIV-infected individuals have also reported lower quality oflife (QoL) than their 
non-infected counterparts (Miners et al., 2001). The majority of the research on QoL 
among persons living with HIV I AIDS shows that women report poorer QoL than men, 
particularly in the psychological and emotional domains (Pereira & Canavarro, 2011; 
Mrus, Williams, Tsevat, Cohn, & Wu, 2005; Peltzer & Phaswana-Mafuya, 2008). Older 
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women with HIV also report lower overall QoL than younger women with HIV, 
particularly in the independence and spirituality domains (Pereira & Canavarro, 2011; 
Piette, Wachtel, Mori, & Mayer, 1995). Psychological problems, particularly depression 
and anxiety that often accompany HIV infection, significantly contribute to lower quality 
of life (Andrinopoulos et al., 2011). Employment, income higher than minimum wage, 
and higher education were significantly associated with higher QoL in HIV -infected 
women, and recent HIV/AIDS diagnosis and less than two years of ART were 
significantly related to lower QoL (Reis, Santos, & Gir, 2012). Lower QoL has also been 
associated with the stress and stigma ofHIV diagnosis (Mahalakshmy, Premarajan, & 
Hamide, 2011) and to decreased likelihood of highly active anti-retroviral therapy (Cook, 
et al, 2002). Racial and gender discrimination stress for African-American women 
undoubtedly contribute to higher anxiety and depressive symptoms and decreased quality 
oflife. Despite the importance of these issues, no systematic studies have been 
conducted looking at quality of life in relation to discrimination or critical consciousness 
in African-American women with HIV. 
HIV and Cardiovascular Risk. The increased cardiovascular risk associated 
with HIV is particularly alarming considering that the mortality rate due to coronary heart 
disease (CHD) is highest among African-American women, accounting for 41.6% of 
deaths, in comparison with other racial/ethnic groups, (Gillum, 1991). Deaths due to 
CHD are 67% higher among Black women than among White women; for Black women 
under 55 years, the risk of death due to CHD is 2.5 times the risk for White women 
(Ofili, Igho-Pemu, & Bransford, 1999). Obesity and being overweight, cigarette smoking, 
high cholesterol, and hypertension are risk factors for cardiovascular disease and are 
often exacerbated in the context of HIV infection. 
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Prior to the introduction ofHAART, HIV infection was associated with weight 
loss and wasting (Smit et al., 2002). Rates of being overweight or obese at the time of 
HIV diagnosis have increased almost two- and four-fold, respectively from the pre-
HAART (1985-1990) to HAART (1996-2004) eras, reflecting weight patterns simliar to 
those of the general U.S. population (Crum-Cianflone, Tejidor, Medina, Barahona, & 
Ganesan, 2008). Among HIV -infected persons, women, and in particular African-
American women, are more likely to be more obese than men (Amorosa et al., 2005). 
Being overweight was a significant predictor of coronary heart disease risk over ten years 
in HIV -infected men and women (Kaplan et al., 2007). In addition to adverse effects of 
being overweight and of obesity on cardiovascular health, there may be a direct link 
between weight and immune functioning in people living with HIV. In a prospective 
study of U.S. veterans, Crum-Cianflone et al. (2010) found that in the HAART era, being 
overweight and/or obese were related to smaller CD4+ cell count increases compared to 
their normal weight counterparts in HIV -infected individuals. This is in contrast to the 
relationship between being overweight and higher CD4 cell counts in pre-HAART era, 
when increases in weight may have staved off opportunistic infections. Other somewhat 
contradictory research from a longitudinal study ofHIV-infected women found that 
obesity to be related to higher CD4 cell counts (Womack et al., 2007). While more 
research is needed to understand the effects of obesity on immune system functioning, the 
higher risk of cardiovascular illness associated with obesity make it a HIV -related health 
outcome in need of attention. 
In addition to increasing risk of cardiovascular disease, cigarette smoking was 
found to inhibit HAAR T response in decreasing viral load and increasing immune 
functioning and to relate to increased rates of AIDS diagnosis and death in women 
(Feldman et al., 2006). Cigarette smoking also adds to the risk of other infections in the 
context ofHIV infection. Compared with women at-risk for HIV, women with HIV who 
smoked cigarettes were more likely to contract the human papillomavirus (HPV; 
Minkoff, 2004). HIV-infected and uninfected African American/Black women were less 
likely to have ceased cigarette smoking over a one-year period compared to White and 
Hispanic women (Goldberg et al. , 2010). Cigarette smoking contributes to range of poor 
health outcomes in the context of HIV infection, relating to a substantial proportion of 
non-AIDS related deaths among women (Cohen et al., 2002). 
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While African-American women generally have lower cholesterol levels than 
Caucasian women (41.2% versus 47%, respectively, have cholesterol levels above 200 
mg/dL), they are at greater risk for cardiovascular disease (American Heart Association, 
2012). HIV-infection and some ART medications increase cholesterol levels (Grinspoon 
& Carr, 2005). Hypertension is associated with traditional risk factors associated with 
higher diastolic and systolic blood pressure, such as male sex, higher BMI, older age, and 
high total cholesterol in HIV-infected individuals (Thiebaut et al. , 2005). Risk factors for 
hypertension in women with and at risk for HIV also included traditional risk factors such 
as African American race, being overweight and older age (Khalsa et al., 2007). In a 
predominantly Black HIV -infected male sample with hypertension, detectable viral load 
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was associated with greater average arterial pressure (Monroe, Chander, & Moore, 2011). 
Thus, cardiovascular disease is a particularly important HIV-related health issue for 
African-American women. Perceived discrimination and discrimination-related stress 
may also play an important role in cardiovascular risk in HIV-infected African-American 
women as both have relationships with hypertension and smoking, risk factors for poorer 
cardiovascular health (Peters, Benkert, Dinardo, & Templin, 2007; Williams & 
Neighbors, 2001; Davis, Liu, Quarells, & Din-Dzietham, 2005; Bennett, Wolin, 
Robinson, Fowler, & Edwards, 2005; Guthrie, Young, Williams, Boyd, & Kintner, 2002). 
However, again, little systematic research has investigated the impact of multiple sources 
of perceived discrimination and DS in relation to cardiovascular risk outcomes in 
African-American women. 
HIV and Alcohol and Substance Use. High rates of alcohol and substance abuse 
are found in HIV-infected persons. In a sample of mostly racial/ethnic minority HIV-
infected women, almost one-third used crack in the past six months, and persistent use 
contributed to a significantly higher likelihood of developing AIDS-defining illnesses, 
faster HIV disease progression, and AIDS-related mortality (Cook et al., 2007). 
Hazardous levels of alcohol use ( 4 or more drinks per day or more than 7 drinks per 
week) were found in 1 out of 5 HIV-infected women (Cook et al. , 2009). Alcohol use 
was associated with lower HAART adherence in women (Lillie-Blanton et al. , 2005). In 
their review, Chander, Himelhoch, & Moore (2006) found in several cohort and cross-
sectional and prospective studies of HIV -infected individuals that, with the exception of 
marijuana, alcohol and illicit drug use were associated with poorer antiretroviral 
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adherence, which then impacted virological and immunological response to treatment. 
However, former drug use was not associated with poorer antiretroviral adherence while 
current drug use among HIV-infected women was found to relate to lower quality oflife, 
higher likelihood of sexual transmitted disease, and a higher number of sexual partners 
(Lucas et al., 2001). 
In summary, among HIV -infected individuals, a number of psychosocial factors 
are related to lower ART medication adherence and HIV disease progression. In 
particular, African-American ethnicity and depression are directly related to lower ART 
medication adherence, HIV disease progression, and increased cardiovascular risk. 
Alcohol and illicit drug use are highly prevalent in HIV -infected populations and also 
strongly associated with poorer ART adherence and thus disease progression (Novotna et 
al., 1999). 
A key risk factor for higher rates of depression and substance use may be the 
greater degree to which African-American women are exposed to discrimination and 
experience discrimination-related stress compared to women of other ethnicities and to 
African-American men, given their multiply disempowered position in the social, 
political, and economic hierarchy. HIV-infected African-American women may also 
perceive higher levels of racial and gender discrimination than African-American women 
without HIV due to additional stigma and discrimination associated with living with HIV 
that may contribute to increased sensitivity to differential treatment. Finally, the addition 
ofHIV discrimination to factors associated with PGD and PRD for African-American 
women likely contribute to global and chronic stress (Geronimus, 2001; Lewis et al., 
2006) that may help to explain the racial discrepancies in HIV health. 
Perceived racial and gender discrimination 
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Racism and sexism are rooted in systematic imbalances in social, economic, and 
political power based on race and gender, in which subordinated groups are cast as 
inferior and discrimination is one of the manifestations of the social hierarchy. It is 
important to note that PRD and PGD have been assessed by self-report, so that it is not 
possible to disentangle actual experiences of discrimination from perceptions of 
discrimination. The most conservative interpretation is to assume that PRD and PGD 
measure levels of sensitivity to and awareness of discrimination, rather than levels of 
exposure to discrimination. 
PRD has been found to relate to a variety of indices of poorer mental and physical 
health among African Americans. A large body of cross-sectional research supports the 
relationship between PRD and poorer mental health, including psychological distress and 
depressive symptoms. Longitudinal research with African American youth has shown 
positive relationships between PRD and conduct and depressive symptoms and inverse 
relationships between PRD and self-esteem (Brody et al., 2006; Greene, Way, & Pahl, 
2006). Some studies have shown that PRD is associated with hypertension in men 
(Krieger & Sidney, 1996; Williams & Jackson, 2001), although other studies have not 
found relationship between PRD and hypertension among African-American women 
(Brown, Matthews, Bromberger, & Chang, 2006) and African American adolescents 
(Matthews, Salomon, Kenyon, & Zhou, 2005). Laboratory studies have shown that 
experimentally manipulated racial discrimination leads to increases in blood pressure but 
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longer-term effects of racial discrimination on blood pressure elevations are still 
unknown (Richman, Bennett, Pek, Siegler & Williams, 2007; Clark, 2006). Higher PRD 
has also been related to behaviors that are detrimental to physical health such as cigarette 
smoking, a behavior that increases cardiovascular risk (Bennett, Wolin, Robinson, 
Fowler, & Edwards, 2005; Williams et al. , 2003; Guthrie et al., 2002; Landrine & 
Klonoff, 1996), increased alcohol consumption (Broman, 2007), and lower adherence to 
physician recommendations (Penner et al. , 2009) in African Americans. 
There has been less research attention paid to the relationship between PGD and 
physical health outcomes, but research on the effects of PGD has also demonstrated its 
consistent association with poorer psychological adjustment (Greer, 2011 ; Landrine & 
Klonoff, 1996; Landry & Mercurio, 2009; Moradi & Subich, 2003 ; Szymanski & 
Stewart, 201 0;), illicit drug use (Ro & Choi, 2011 ), and decreased adherence to 
mammography recommendations (Dailey, Kasl, & Jones, 2008). Perceived gender 
discrimination has also be associated with heavier smoking and binge-drinking in young 
adult women, and this relationship was mediated by general psychological distress 
(Zucker & Landry, 2007). 
These results suggest that PRD and PGD contribute to psychological distress, 
physical health problems, and behaviors such as smoking, alcohol use, and lower 
adherence to health recommendations that may in tum lead to poorer physical health. 
While much of the literature examined the unique contributions of PRD with men and 
women or PGD with women of different races/ethnicities, recent work has begun to 
examine effects of multiple forms of discrimination. This research, reviewed next, will 
help to better understand the effects of multiple sources of discrimination that are 
experienced by individuals belonging to multiple oppressed social groups such as 
African-American women. 
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Multiple sources of discrimination. African-American women are more likely 
than Caucasian women to report experiencing unfair treatment, acute life events, and 
have fewer economic resources at any given educational level (Schulz et al., 2000). 
Coping with the excessive stress that comes with the social, political, and economic 
conditions associated with being African American and female (Geronimus, 2001), 
including racial and gender discrimination and discrimination-related stress, may 
contribute to the significantly higher levels of chronic morbidity and disability among 
African-American women. Some research suggests that the effects of both PRD and PGD 
on health cannot be disentangled and interact with other daily stressors to contribute to 
global stress, which is itself predictive ofhealth outcomes. For example, in a model of 
global stress based on reports of exposure to and appraisal of three types of stress, 
gender-related, race-related, and general stress, Woods-Giscombe & Lobel (2008) found 
that the higher-order global stress factor predicted psychological distress for African-
American women better than each of the three types of stress individually. There is 
evidence to suggest that awareness of one form of discrimination is related to awareness 
of other forms, possibly because sensitization to discriminatory experiences can lead to 
greater awareness of other subordinated aspects of one's identity. Krieger (1990) found 
that among African-American women, those reporting racial discrimination were more 
likely to also report gender discrimination and women reporting no racial discrimination 
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were also more likely to deny experiences of gender discrimination. Moreover, the 
significant relationship that Lewis et al. (2006) found between perceived discrimination 
and greater coronary artery calcification (CAC), a measure of coronary heart disease risk, 
in African-American women did not vary as a function of attribution to race or gender for 
discrimination, demonstrating the integrative nature of racial and gender discrimination 
in predicting adverse physical health outcomes. In contrast to research that demonstrated 
the indivisibility of different sources of discrimination, other studies have shown 
differential and unique effects of perceived racial versus gender discrimination on 
psychological distress. When examining PRD and PGD simultaneously, some studies 
have found that only PRD significantly predicted psychological symptoms (King, 2005), 
while others have found this effect only for PGD (Moradi & Subich, 2003; Canady, 
Bullen, Holzman, Broman, & Tian, 2008; Szymanski & Stewart, 201 0). 
In summary, the impact of multiple forms of perceived discrimination on 
psychological distress in African-American women is not well-understood. The present 
study seeks to address this limitation by examining the impact of PRD and PGD when 
investigated simultaneously to understand their roles in psychological symptoms, health 
behaviors and outcomes among African-American women with HIV. 
Discrimination-related stress. Individual differences in levels of DS due to PRD 
and PGD may be an important contributor to health outcomes, above and beyond the 
levels of reported PRD and PGD. The stress resulting from discrimination perceived to be 
because of one's race and/or gender is considered to be more detrimental to health than 
generic stressors (such as illness or parenting) because of its demeaning and 
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uncontrollable nature, contributing to increased risky health behaviors, reduced 
engagement in health sustaining behaviors, and compromised immune function 
(Landrine, & Klonoff, 1996; Moradi & Subich, 2003 ; Broman, Mavaddat, & Hsu, 2000). 
OS has also been found to contribute to maladaptive coping strategies such as illicit drug 
use (Ro & Choi, 201 0). Stress from chronic, everyday discrimination in middle-aged, 
higher-SES, African-American women was related to higher CAC after controlling for 
body mass index, depression and hostility (Lewis et al., 2006). 
For the most part, research on PRD and PGD and DS has not systematically 
differentiated perceptions of stress from stress experiences. While there is ample 
evidence showing the relationship between PRD and depressive symptoms and global 
psychological distress in African-Americans (Banks, Kohn-Wood, & Spencer, 2006; 
Williams, Yu, Jackson, & Anderson, 1997), fewer studies have asked for reports of stress 
in direct relation to perceived discrimination (i.e. how stressful individuals find 
discrimination to be). There is some evidence to show that the constructs ofPRD and DS 
are different from each other. DS mediated the relationship between PRD and smoking in 
adolescent African American girls, and between PGD and illicit drug use in women 
(Guthrie et al., 2002; Ro & Choi, 201 0). In a study of African Americans, Davis, Liu, 
Quarells, & Din-Dzietham (2005) measured the presence ofPRD and the magnitude of 
stress response to the PRD separately and examined each individually in relation to 
hypertension. They found that PRD did not relate to hypertension but that DS doubled the 
likelihood of hypertension in their sample. The present study seeks to extend these 
findings by measuring the effects ofPRD, PGD, and DS in relation to mental and 
physical health outcomes in African-American women with and at risk for HIV. 
Coping with Discrimination 
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Coping involves a cognitive or behavioral response to an appraisal of a stressor 
that can be more or less adaptive to the situation at hand and can also vary in its 
flexibility as applied across a variety of circumstances (Lazarus & Folkman, 1984). The 
type of strategy used to cope with perceived discrimination may be a better predictor of 
physical health and psychological adjustment than the severity and/or type of 
discrimination (Barroso & Sandelowski, 2004). For example, in a study of discrimination 
and blood pressure in women, Krieger (1990) found that African-American women were 
more likely to report using avoidance and passivity when faced with discrimination 
compared with White women. However, African-American women who endorsed taking 
action in response to unfair treatment reported having lower blood pressure than those 
who endorsed acceptance and "remaining quiet." African-American women who denied 
any instances of discrimination had higher risk of hypertension than those who reported 
at least one instance. Greater use of denial or avoidance coping (not necessarily related to 
discrimination) has been linked to HIV disease progression (Leserman et al., 2000; 
Antoni, Schneiderman, Esterling, Ironson, 1994; Ironson et al., 2005) while active, 
confrontational coping styles were related to slower HIV disease progression (Mulder, 
Antoni, Duivenvoorden, Kauffmann, & Goodkin, 1995). These results suggest that 
acknowledgement of discrimination and taking action against it may relieve the burdens 
of suppression and that a general approach-oriented coping style, rather than an avoidant 
style, relates to better physical and HIV -related health. It may also be that awareness of 
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discrimination and of the ways that broader social systems can impact one's life can also 
be protective and promote psychological and physical well-being in African-American 
women with HIV. It is also important to remember that coping with HIV is complex and 
that positive outcomes also depend on a range of other factors, such as emotional and 
financial resources as well as social supports (Moscowitz, Hult, Bussolari, & Acree, 
2009). 
Critical consciousness. Critical consciousness refers to an awareness of social 
inequality and its impact on individuals (Gurin, Miller, & Gurin, 1980). Paulo Friere first 
coined the term critical consciousness, or "conscientization," in The Pedagogy of the 
Oppressed (1970) to refer to a progression of levels of consciousness about socio-cultural 
realities in people's lives that culminates into recognition of one's capacities to enact 
social change on those realities. Such awareness may be protective against the 
deleterious effects of discrimination and is an approach-oriented way of coping in 
contrast to the avoidance-oriented denial of structural inequities that tolerates racial and 
gender discrimination. It also is in contrast to self-blame and blaming individuals for poor 
conditions in their lives. Among African Americans, greater denial of racial inequity has 
been related to higher levels of victim-blaming attributions for racial inequality, 
internalized oppression, and justification of social roles or social dominance orientation 
(Neville, Coleman, Falconer, & Holmes, 2005). Critical consciousness involves not only 
an awareness of sociopolitical inequality but also the empowerment of individuals to 
engage in social change (Friere, 1973). 
Social psychologists Gurin, Miller & Gurin (1980) defined four dimensions of 
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critical consciousness in their theory that sought to describe the key components or 
dimensions of critical consciousness. The first is Identification, the recognition of 
membership in a group that shares similar social features and values. The second and 
third dimensions comprise political consciousness : Power Discontent refers to the level 
of awareness and acceptance of power imbalances among social groups within a broader 
social, political, and economic hierarchical system; Legitimacy of Disparities refers to the 
attribution of social conditions/disparities to either individual or systemic causes, also 
known as "system-blame." The fourth component of critical consciousness is Collective 
Orientation, a tendency to enact social change by joining with others who have similar 
pursuits. When examining relationships among the dimensions, African-American men 
and women who most closely identified with race (as opposed to gender or 
socioeconomic status) were found to be more politically conscious, endorsing greater 
discontent with the distribution of social power and attributing responsibility to the 
system for social conditions. For both White women and African-American men and 
women, attributing manifestations of oppression to the system versus to the individual 
most strongly predicted endorsement of a collective action orientation. 
The awareness of the nature of the inequitable and arbitrary social system context 
in which unfair treatment is propagated may be an important protective factor when 
coping with PGD, PRD, and DS. Critical consciousness may help to challenge feelings of 
powerlessness that can lead to psychological distress, negative health behaviors and 
outcomes by its acknowledgement of racial and gender disparities and rejection of the 
validity of structural power imbalances that produce and maintain discrimination and 
19 
stress. External attributions for experiences with discrimination, whether it be HIV-
related, race-related, gender-related, or related to other aspects of self, may promote the 
use of active coping strategies and better health management and differ from general 
external attributions (Schmitt & Branscombe, 2002). For example, feminist 
consciousness, defined as having high group identification, high centrality of gender to 
identity, and positive evaluation of women as a group, was found to buffer against high-
risk health behaviors (Zucker, Stewart, Pomerleau, & Boyd, 2005). Women high in 
feminist consciousness were more likely to have never smoked cigarettes. In addition, ex-
smokers endorsed a more critical perspective about sexist advertising than current 
smokers. 
In an experimental study of ethnic consciousness, defined as recognition of 
structural inequalities faced by one's ethnic group, Brown & Johnson (1999) found that 
in a hypothetical situation in which the employment of an African American individual 
was terminated at a firm, African Americans high in ethnic consciousness blamed the 
White firm for the termination more than they blamed the individual African American 
employee and found the termination to be more punitive than did African Americans low 
in ethnic consciousness. There were no significant differences in blame or judgment of 
punitiveness as a function of ethnic consciousness for a scenario in which a Black firm 
terminated a European American employee, but on average, participants low in ethnic 
consciousness blamed the African American employee more than did the participants 
high in ethnic consciousness. This study suggests that greater awareness of structural 
inequality is associated with external attributions of blame for racial discrimination. 
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Attributing lack of success to system biases has been shown to buffer against 
psychological distress in young African American males in the context of goal-striving 
stress, defined as "the discrepancy between aspirations and achievement" in the context 
of education and career goals (Sellers, Neighbors, & Bonham, 2011). 
The evidence suggests that critical consciousness may be an important coping 
strategy and tool for empowerment for socially marginalized groups. However, the 
development and correlates of critical consciousness are understudied. Gurin, Miller, & 
Gurin (1980), in their original study on the four dimensions of critical consciousness, 
theorized that membership in subordinated groups (e.g., women, Blacks, members of the 
working class); the amount and quality of time spent with members of the subordinated 
groups to which one belongs; and a pre-existing ideology about group hierarchy 
promoted identification with subordinated groups. Identification, defined in this way, 
comprises exposure and interaction with members of a social group and a budding 
awareness of the group's status in the social hierarchy, which then aids in the 
development of critical consciousness. Gurin and colleagues (1980) found that compared 
with Caucasians, African Americans were more closely identified with race. Between the 
two groups, African Americans more closely identified with race were also more 
collectively oriented in beliefs for social change and rejecting of system legitimacy than 
Whites who closely-identified with their race. Their findings suggest that pre-existing 
ideology about group inequality was important to the development of critical 
consciousness. In a study of marginalized youth, Diemer & Li (2011) found that peer and 
parental support of sociopolitical thinking and discussion predicted higher sociopolitical 
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control, or the self-efficacy to effect social and political change, and a higher likelihood 
of engaging in social action. Thus demographic characteristics, particularly African 
American race, contribute to the development of critical consciousness as well as having 
education about sociopolitical affairs. However, more systematic investigation is needed 
to fully understand the determinants and correlates of critical consciousness, particularly 
when taking into account multiple memberships in different social groups. Life 
experiences with discrimination may be a powerful antecedent of awareness of social 
inequality. For example, African Americans who endorsed having more experiences with 
racial discrimination also attributed the disproportionate incarceration rate of Black men 
to structural causes (Unnever, 2010). 
Additional examination of the psychosocial and health correlates of critical 
consciousness is needed to understand its effects as a means of coping with 
discrimination stress as well as to provide a better understanding of its relationship to 
health and well-being in African-American women with HIV. Elaboration ofthe critical 
consciousness construct, which has been limited in previous research, will make a 
significant contribution to understanding the relationship between psychological coping, 
contextual factors , and health in African-American women, a group that has been 
disproportionately affected by HIV. 
Critical consciousness and incarceration. Experience with the criminal justice 
system may also contribute to the development of critical consciousness. Little attention 
has been given to women affected by the criminal justice system, consisting of 
approximately 1 million who are under some form of correctional supervision (e.g., jail, 
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prison, on probation), of which a disproportionate number are women of color (West, 
201 0). Thirty percent of African-American women are incarcerated at some point in their 
lives, and 2.4% of women incarcerated are infected with HIV (The Sentencing Project, 
2007). The prevalence of HIV is twice as high for female than for male inmates and 
incarcerated women are 15 times more likely than non-incarcerated women to be infected 
by HIV (De Groot & Cu Uvin, 2005). A higher proportion of women are imprisoned for 
drug-related crimes than men (Talvi, 2007; Cooper, Sabol, & West, 2009). A majority of 
HIV -infected women were likely infected prior to their incarceration and were exposed to 
factors associated with risk for HIV and for incarceration, such as relationships with 
high-risk partners and involvement in substance abuse (Zack, 2007). 
Given the disproportionate rates of incarceration among African Americans 
compared to other racial and ethnic groups, there has been a great deal of discussion 
around the possible racism involved in the incarceration of African Americans 
(Alexander, 2010). It is possible that discrimination, discrimination-related stress, and 
even critical consciousness heighten the possibility ofbeing incarcerated. However, the 
reverse direction of causality may also be true: It is also possible that being incarcerated 
increases awareness of racism, sexism, and the critical consciousness of social and 
structural inequities. However, there is an absence of literature testing these ideas and 
investigating the relationships among incarceration, critical consciousness, PRD and 
PGD. 
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The Present Study 
The current research investigates the relationship of HIV -related health behaviors 
and outcomes with PRD, PGD and DS. Additionally, the role of CC as a buffer against 
adverse health behaviors and outcomes was examined. It has been demonstrated that 
PRD and PGD are associated with poorer general and HIV -specific psychological and 
physical health outcomes. The specific objectives of the research were to investigate: (1) 
the relationships among PRD, PGD, and DS and HIV -specific and other health behaviors 
and outcomes in African American HIV-infected women; (2) the role ofCC as a 
protective factor against poorer health outcomes in African American HIV -infected 
women; (3) the differences between HIV -infected women and women at risk for HIV in 
PGD, PRD, and DS, and health outcomes, and (4) the relationships among incarceration 
and PRD, PGD, DS, CC, and substance abuse in HIV-infected women and women at risk 
forHIV. 
Aim 1. Aim 1 examined the associations between PGD, PRD, and DS with 
depressive symptoms, quality of life, cardiovascular risk factors, alcohol and substance 
use, ART adherence, and HIV disease indicators in HIV-infected African-American 
women. 
Hypothesis 1. When examined simultaneously, higher levels of PRD and PGD 
will significantly relate to higher depressive symptoms, lower quality of life, 
current/former use of alcohol and illicit drugs, the presence of cardiovascular risk factors 
(e.g., current smoking, higher blood pressure, higher total cholesterol and body mass 
index, and lower HDL cholesterol), lower ART adherence and higher HIV disease 
markers (e.g. , lower CD4 cell count and higher viral load) in HIV -infected African-
American women. 
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Hypothesis 2. When adding DS to the model with PRD and PGD, DS will help 
explain the associations ofPRD and PGD with higher depressive symptoms, lower 
quality oflife, current/former substance use, lower ART adherence, the presence of 
cardiovascular risk factors (e.g., current smoking, higher blood pressure, total cholesterol, 
and body mass index, and lower HDL cholesterol), and higher HIV disease markers (e.g. , 
lower CD4 cell count and higher viral load) in HIV-infected African-American women. 
Aim 2. To examine DS as a mediator ofthe relationships between PGD and PRD 
and depressive symptoms, quality of life, cardiovascular risk factors, ART adherence, 
and HIV disease markers in HIV-infected African-American women. 
Hypothesis 3. PRD and PGD will have direct effects, and indirect effects through 
DS, on health behaviors and outcomes. PRD and PGD will significantly directly relate to 
higher depressive symptoms and cardiovascular risk factors, and lower quality of life and 
ART adherence, and poorer HIV disease markers; PRD and PGD will significantly 
positively relate to DS; and DS will significantly relate to higher depressive symptoms 
and cardiovascular risk factors, and lower quality of life and ART adherence, and poorer 
HIV disease markers in HIV-infected African-American women. 
Aim 3. To examine CC as a moderator of the effects ofPRD, PGD, and DS on 
health behaviors and outcomes in HIV-infected African-American women. 
Hypothesis 4. Higher CC will significantly positively relate to higher PGD, 
PRD, and DS in HIV -infected African-American women. 
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Hypothesis 5. Higher CC will significantly positively relate to higher education, 
income, and employment in HIV-infected African-American women. 
Hypothesis 6. Higher CC will significantly positively relate to better HIV -related 
health in terms of higher CD4 cell counts and lower viral load, lower depressive 
symptoms, higher quality of life, lower cardiovascular risk, and no history of substance 
use in HIV-infected African-American women. 
Hypothesis 7. CC will significantly moderate the relationship between DS and 
health outcomes in HIV -infected African-American women such that at higher levels of 
DS, participants with lower CC will have worse health behavior and outcomes than 
participants with higher CC and other combinations of scores on CC and DS. 
Hypothesis 8. CC will significantly moderate the relationship between PGD and 
health outcomes in HIV-infected African-American women such that at higher levels of 
PGD, participants with lower levels of CC will have worse health and heath behavior 
outcomes than participants with higher CC and other combinations of scores on CC and 
PGD. 
Hypothesis 9. CC will significantly moderate the relationship between PRD and 
health outcomes in HIV-infected African-American women such that at higher levels of 
PRD, participants with lower CC will have poorer health outcomes than participants with 
higher CC and other combinations of scores on CC and PRD. 
Hypothesis 10. Collective action orientation (CAO), a dimension of CC, will 
significantly moderate the effects ofDS on health outcomes in HIV-infected African-
American women such that at higher levels of DS, participants with lower CAO will have 
worse health outcomes than participants with higher CAO and other combinations of 
scores on CAO and DS. 
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Aim 4. To examine differences between HIV -infected and matched samples of 
HIV-uninfected African-American women in PRD, PGD, DS, and CC in relation to 
depressive symptoms, quality oflife, cardiovascular risk, and substance use. No specific 
hypotheses were posited given the absence of previous literature on this topic. 
Aim 5. To examine how levels of critical consciousness and patterns of 
relationships among PRD, PGD, DS, and CC, and health outcomes are related to 
women's experiences with incarceration. Here again, no specific hypotheses were posited 
given the absence of previous literature on this topic. 
Participants 
CHAPTER2 
Methods 
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Participants were a sub-sample of women enrolled in the Women's Interagency 
HIV Study (WIHS). The WIHS is an ongoing longitudinal multi-center cohort study that 
initially enrolled HIV-infected and demographically matched HIV-uninfected women in 
1994 to 1995 and a second wave in 2001to 2002 in six US cities. All participants in the 
present study were enrolled in the Chicago site of the WIHS. Women attend study visits 
every six months in which they complete an interviewer-assisted questionnaire in 
English. Data for the present study were collected during study visits 30 and 31 
occurring in 04/01/2009 to 03/31/2010. 
Seventy-three African-American women with HIV and 25 without HIV who were 
matched on socio-demographics and risk factors (age range was 26 to 72 years) were 
enrolled in the present cross-sectional study. The sample's demographic characteristics 
are displayed in Table 2.1. HIV-infected women tended to be older (M= 45.91, SD = 
8.83) than uninfected women (M= 41.91, SD = 10.62; t = -1.86,p = .06). There were no 
other differences found in demographic characteristics by HIV status. The sample as a 
whole was economically very poor, with the majority (64%) reporting an annual income 
under $12,000. Thirty-six percent of the participants completed junior or partial high 
school and an additional 40% completed high school. Seventy-two percent of the sample 
was unemployed. Forty-eight percent of the participants were never married, 16% were 
legally or common-law married, and 8% were living with their partner. 
Procedure 
Study measures were collected immediately following the regularly scheduled 
WIHS study visit unless participants opted to complete questionnaires at a return visit 
within 7 days. Inclusion criteria included African American or Black race, and being 
enrolled in the WIHS. Exclusion criterion included the presence of active psychotic 
symptoms. Research staff provided potential participants with information about the 
current study. Once the eligible WIHS study participant and research staff determined 
that there was a complete understanding of the study and procedures, those willing to 
participate signed informed consent documents. Participants were also able to defer 
enrollment if they required additional time to decide on participation or preferred to 
discuss their participation in the study with others. The participant was then enrolled in 
the current study and completed the measures, which were read aloud to them, as per 
standard WIHS procedures. Study sessions were conducted in private rooms to assure 
confidentiality. Transportation and on-site childcare were provided as needed. 
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Data collected specifically for the current study were derived from measures 
developed and selected by the present investigator, who then supervised trained WIHS 
research staff to administer the measures. Measures included self-report questionnaires 
of racial and gender discrimination and critical consciousness. These measures were 
adapted from standard measures in the literature after being piloted on focus groups of 
Community Advisory Board members and discussed in consultation meetings between 
the Board and the present investigator to ensure cultural sensitivity. 
Additional variables were collected as a part of routine WIHS bi-annual study 
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during visits 30 and 31. During WIHS visits, participants complete a detailed, structured 
interview, brief physical and gynecologic examination, and specimen collection. Full 
descriptions ofWIHS study visit protocols have been previously published (Barkan et al., 
1998). Trained research staff orally query participants about general and HIV health 
history, medication adherence, and substance use and other health behaviors. Detailed 
reliable instruments were used to measure ART adherence (e.g., standard ART dosage 
information, timing of most recent ART drug dose), and other health behaviors (e.g. , 
smoking, drug and alcohol use) and outcomes (e.g., depressive symptoms, quality of life, 
cardiovascular disease risk factors). Total cholesterol, HDL cholesterol, and CD4 cell 
count and viral load were measured for participants from blood specimens. Blood 
pressure readings were obtained during participants ' physical examination using standard 
methods. 
Measures 
Everyday discrimination. Discrimination was measured with the 15-item, 
modified version of the Detroit Area Study Discrimination Questionnaire (DAS-DQ) 
(Williams, Yu, Jackson, & Anderson, 1997), which assessed the frequency of perceived 
general interpersonal mistreatment, or discrimination, in day-to-day life. The original 
measure contains 9 items such as, "People act as if you are not as good as they are," "You 
are treated with less courtesy than other people." Responses were scored on a 5-point 
Likert-type scale ranging from 1 =never to 5 =very often. The original 9-item DAS-DQ 
has shown high levels of internal consistency (Williams, Yu, Jackson, & Anderson, 1997; 
Banks, Kohn-Wood, & Spencer, 2006) and convergent and divergent validity (Taylor, 
Kamarck, & Shiffman, 2004) in samples of African-American men and women. The 
DAS-DQ has excellent predictive validity for symptoms of depression and anxiety, 
environmental mastery, and coronary artery calcification (Keith, Lincoln, Taylor, & 
Jackson, 2010; Banks, Kohn-Wood, Spencer, 2006; Lewis et al., 2006). 
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Modifications of the DAS-DQ for the current study included additional questions 
assessing the attribution of perceived discrimination to gender and race. Each of the 
original 9 DAS-DQ items had three additional sub-questions. All responses were rated on 
a 5-point scale. After each question assessing general discrimination, to assess perceived 
racial discrimination (PRD), the participant was asked, "How much do you think your 
race had to do with this?"; to assess perceived gender discrimination (PGD), the 
participant was asked, "How much do you think your gender had to do with this?" The 
order in which each attribution was assessed (i.e. race or gender) was alternated every 
other question to reduce automatic responding and to balance response options. Lastly, to 
assess discrimination-related stress, participants were asked, "How upset/stressed were 
you about this treatment?" Six additional items assessed racial and gender discrimination 
directly and included, for example, "How often do people treat you unfairly because of 
your gender?" and "How often do people treat you unfairly because of your race?" Each 
was followed by a question assessing discrimination-related stress associated with that 
item. Four subscales were created from the mean of items: general perceived 
discrimination (PD), PGD, PRD, and DS. 
Critical consciousness (CC). The CC questionnaire was developed for the 
present study by using examples from published studies that investigated the construct of 
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critical consciousness, and pilot testing items with the Community Advisory Board at the 
WIHS Chicago site and with direct consultation with some of its members and other 
expert consultation. This measure consisted of20 items assessing four dimensions of 
critical consciousness, identification, power discontent, rejection of system legitimacy, 
and collective action orientation, based on the theoretical model developed by Gurin et al. 
(1980). All responses were rated on a 5-point scale except where noted. Two items 
assessed identification with other women and with other African/Black Americans. 
Power discontent was measured by asking participants to rate their beliefs about the 
power of several social groups in society. Rejection of system legitimacy, or of the status 
quo, was measured with four pairs of opposing statements for which participants were 
asked how much they agreed or disagreed with each statement, representing emphases on 
structural inequities versus individual culpability (e.g., "More African/Black Americans 
are in prison because the legal system has different standards for different races;" and 
"More African/Black Americans are in prison because they commit more crimes than 
people of other races."). Collective action orientation was measured with a rank-ordering 
method in which participants were asked to rank six activities in order of preference for 
how they might engage in action to promote social change. Three options were 
individually-oriented (e.g., voting in local and national elections) and three were 
collectively-oriented (e.g., Being active in a church group or organization). The rankings 
were then reverse-coded and the average calculated so that higher scores indicated higher 
collective action orientation. A total critical consciousness score was calculated by 
standardizing all items so that all were on the same metric prior to summing for a total 
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mean score. Participants were also asked two questions about their beliefs about the need 
for social and political change, which were not included in the total critical consciousness 
score. One question asked about beliefs for change on behalf of women (e.g., "How much 
do you think that political and social change is necessary for women?") and the other on 
behalf of African/Black Americans (e.g., "How much do you think that political and 
social change is necessary for African/Black Americans?") 
ART adherence. The WIHS definition ofHAART is guided by the DHHS/Kaiser 
Panel guidelines and was defined as: the reported use of three or more antiretroviral 
medications, one of which is a PI, an NNRTI, one of the NRTis abacavir or tenofovir, an 
integrase inhibitor (e.g., raltegravir), or an entry inhibitor (e.g., Maraviroc or enfuvirtide). 
Each participant was asked to bring in either her medication bottles or a list from the 
pharmacy or physician or to identify the medications from picture cards provided by 
WIHS staff and was then asked to specifically recall her adherence to each drug of the 
current antiretroviral regimen. The participant was asked to pinpoint on a response card 
(showing percentages from 0-100%) their best guess at the percentage of the specific pills 
she took in the past 6 months. Responses were coded with five categories: 1= 100% of 
the time, 2= 95-99% of the time, over past 6 months, 3= 75-94% of the time, 4= < 75% of 
the time, 5= I haven't taken any of my prescribed medications. A 95% ART adherence 
rate has been found to significantly inhibit HIV disease progression. Thus, in addition to 
investigating ART adherence as a continuous scale (1 - 5); a categorical variable was 
created reflecting medications taken 95% or more, versus less than 95%, of the time. 
HIV disease markers. During WIHS visit 31, blood specimens were analyzed for 
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CD4+ cell count and HIV RNA load or level, given in copies per milliliter of blood. 
Analyses used a continuous measure of CD4 cell count, as well as a categorical variable 
with a cut-off of 500 cells/mm3. The cut-off of 500 cells/mm3 was used because 
antiretroviral treatment is indicated when CD4 cell counts fall below 500 cells/mm3 and a 
normal CD4 count ranges from 500-1,000 cells/mm3. The logarithmw-transformed HIV 
viral load was used as a continuous variable and was also dichotomized as detectable ( ~ 
50 copies/ml) or undetectable(< 50 copies/ml). 
Cardiovascular risk. Fasting cholesterol serum specimens for lipids were 
collected, including total cholesterol and high-density lipoprotein (HDL) cholesterol. 
HDL cholesterol was used as a continuous measure and as a categorical measure with a 
cut-off of 40 milligrams per deciliter (mg/dL). Cholesterol was used as a continuous 
measure and as a categorical measure with a cut-off of 200 mg/dL. Body Mass Index 
(BMI) was calculated as weight in kilograms divided by the square of height in meters 
and was used continuously and with a cut-off of 25 as overweight. Seated diastolic and 
systolic blood pressure measurements were made with standard procedures during the 
medical examination. Blood pressure was used as continuous variables and as categorical 
variables with a diastolic blood pressure cut-off of 140 millimeters of mercury (mmHg) 
and a systolic blood pressure cut-off of 90 mmHg. 
Depressive symptoms. The Center for Epidemiological Studies Depression Scale 
(CES-D Scale; Radloff, 1977) is a 20-item, self-report measure of current, affective 
depressive symptoms and is widely used in studies of women with HIV. Participants 
rated their level of agreement with each item on a 4-point scale. The CES-D shows high 
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internal consistency and moderate test-retest reliability. The CES-D has been successfully 
validated against clinical interview as the gold standard with low-income women 
(Thomas, Jones, Scarinci, Mehan & Brantley, 2001) and has been used extensively in 
studies with HIV-infected individuals (Ickovics et al., 2001; Cook et al., 2004; Moore et 
al., 1999). The CES-D total score was used as an outcome variable in the present study. 
Three summary scores were used: (1) a continuous measure with total scores ranging 
from 0 to 80, (2) a dichotomous score with 16 as the cut-off score, and (3) a dichotomous 
score with 23 as the cut-off score. The cut-off scores of 16 and 23 are modeled after 
methods described in Cook et al. (2002). Sixteen is the standard cut-off score for clinical-
level depressive symptoms. Because of the higher than average scores of women with 
HIV, Cook et al. (2002) used a higher score of 23. 
Quality of life. The short form ofThe Medical Outcome Study (MOS)-HIV, a 
widely used disease specific instrument for quality of life, was adapted for use in the 
WIHS and developed by Bozzette, Hays, Berry, Kanouse, & Wu (1995). With this 
shorter version, item redundancy is reduced while reliability is maintained while 
construct validity is comparable to the original measure. All reliability indices were 
above 0.91 and were found to be fairly stable over time. The shortened form has 21 items 
representing 9 domains: physical functioning, role functioning, energy/fatigue, social 
functioning, cognitive functioning, pain, emotional well-being, perceived health index 
and current health perception. A summary score is generated from six domains (physical 
functioning, role functioning, energy/fatigue, social functioning, pain and emotional well-
being) on the basis of a published algorithm. SummaTy scores range from 0 to 100 with 0 
representing low quality of life and 100 representing high quality of life. The summary 
score was used in the present study as an outcome variable. 
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Smoking. As a part of the regular WIHS structured interview, current smoking is 
measured with the question, "Have you smoked cigarettes since your last visit?" with 
yes/no response choices. 
Alcohol use. At each WIHS visit, participants reported the average number of 
days per week they consumed an alcoholic drink since their previous assessment 6 
months earlier. A drink is defined as "1 can, bottle, or glass of beer, a glass of wine, a 
shot of liquor, a mixed drink with that amount of liquor, or any other kind of alcoholic 
beverage." Response options are every day, 5-6 days per week, 3----4 days per week, 1-2 
days per week, less than once per week, and none. Alcohol use was also measured with 
two categories: (1) current or former use and (2) no current or no former use. 
Substance use. The data for use of intravenous drugs, crack, cocaine, or heroin, 
and cannabis are gathered as self-report and are collected as part of the WIHS standard 
semi-annual interview protocol as per NIDA recommendations for measurement of illicit 
drug use. The two categories for substance abuse variables were (1) current or former and 
(2) no current or no former use. 
Incarceration. Incarceration was measured by self-report during the baseline 
WIHS interview. Participants were asked if they had ever been incarcerated. Responses 
were recorded with dichotomous yes/no responses . Data on the frequency of 
incarceration were also collected. Of participants who had ever having been incarcerated, 
they were asked the number of incarcerations they had experienced. 
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Results 
Preliminary Analyses 
Violations of the assumptions of multivariate analyses, including normal 
distribution and extreme outliers (scores greater than two standard deviations above the 
mean) were examined for each variable prior to analysis. Sensitivity tests were performed 
to examine the impact of extreme outliers on all analyses. Extreme outliers and non-
normal distributions were found for the variables: viral load, CD4 cell count, CES-D, 
BMI, and cholesterol. The distribution of viral load was positively skewed and contained 
an extreme outlier. A base-l 0 logarithm transformation was performed on the viral load 
variable to approximate a normal distribution. After removing extreme outliers, 
distributions for CD4 cell count and BMI were normal. Results of analyses after removal 
of extreme outliers did not differ, so the original scores were retained. Square root 
transformations were performed and used in the analyses for CES-D and cholesterol. 
However, results of the transformed variable for CES-D did not differ in the final model, 
so the original variable was retained. The results of analyses for cholesterol were 
dissimilar after the transfonnation so the square root transformation of cholesterol was 
used in all analyses. Eight cases were missing for the ART adherence variable and two 
cases were missing for the collective action orientation dimension of critical 
consciousness (CC) and for the CC total score variable in the HIV-infected group. All 
statistical tests were two-tailed, with an alpha level of .05. All data analyses utilized 
SPSS version 19.0 (IBM, Inc., Chicago IL). 
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Descriptive Statistics 
Means and standard deviations for the entire sample and separately by HIV status 
for the discrimination and critical consciousness predictor variables are displayed in 
Table 3.1 and for continuous outcome variables in Table 3.2. The mean scores for HIV-
infected women are as follows: PRD was 2.22 (SD = .99), PGD was 1.99 (SD = .80), and 
the mean forDS was 2.31 (SD = 1.14). Mean scores of each CC dimension for HIV-
infected women were 3.43 (SD = .96) for identification, 3.43 (SD = .96) for power 
discontent, 3.22 (SD = .92) for rejection of system legitimacy, and 3.67 (SD = .65) for 
collective action orientation. Frequencies and percentages of the dichotomous outcome 
variables for entire sample and by HIV status and results of continuity corrected chi-
square tests between HIV status groups are displayed in Tables 3.3 and 3.4. Table 3.5 
displays the frequencies ofHIV-related variables for the HIV-infected participants. 
Tests of Hypotheses 
Aim 1. Aim 1 examined the associations ofPGD, PRD, and DS with depressive 
symptoms, quality of life, cardiovascular risk factors, alcohol and substance use, ART 
adherence, and HIV disease indicators in HIV-infected African-American women. 
Correlations among PGD, PRD, DS, CC and Outcome Variables. Moderate to 
high significant zero-order correlations were found among predictor variables PGD, 
PRD, and DS. Prior to testing the main hypotheses, correlations were calculated between 
demographic variables (e.g., age, income, education, employment) and predictor and 
outcome variables to identify covariates. Age was positively and significantly associated 
with PGD and PRD and tended to be positively associated with DS (see Table 3.6). 
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Demographic variables significantly correlated with outcome variables (see Tables 3.7 
and 3.8) were controlled in subsequent analyses. Perceived discrimination (PD) was 
included as a covariate to control for varying levels of PD in order to examine the unique 
contributions of gender and racial attributions for the perceived discrimination. 
Tables 3.9 and 3.10 display partial correlations between predictor and outcome 
variables controlling for demographics and PD. In HIV-infected women, controlling for 
age, employment, education, income, and PD, higher PGD tended to relate to 
current/former (versus no current/former) intravenous drug use, r = .23 , p = .06. 
Controlling for age and PD, PGD also tended to relate to hypertensive systolic blood 
pressure (BP), r = .20,p = .09. Controlling for age and PD, higher PRD significantly 
related to lower depressive symptoms, r = .24,p = .047, higher systolic blood pressure 
(BP), r = .25,p = .04, hypertensive systolic BP, r = .26,p = .03, and current/former 
(versus no current/former) cannabis use, r = .24, p = .046, as well as tended to relate to 
hypertensive diastolic BP, r = .23,p = .03. Controlling for age, employment, income, 
and PD, higher PRD significantly related to current/former (versus no current/former) use 
of cocaine, crack, or heroin, r = .24,p = .04. Controlling for age, education, and PD, 
higher DS significantly related to current/former (versus no current/former) cannabis use, 
r = .27, p = .03, and controlling for age, income, and PD, higher DS tended to relate to 
higher CD4 cell count, r = .21,p = .09. 
Hypothesis 1. Hypothesis 1 predicted that higher levels of PRD and PGD would 
significantly relate to higher markers ofHIV disease, lower ART adherence, higher 
depressive symptoms, lower quality of life, higher cardiovascular risk, and higher 
likelihood of substance use in HIV-infected African-American women. 
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Markers of HIV disease and ART adherence. To test the hypothesis that PGD and 
PRD significantly relate to CD4 cell count and viral load (log10 transformed) as 
continuous outcome variables, demographic and PD covariates were entered in the first 
step of hierarchical multiple linear regressions, with PGD and PRD subsequently entered 
in step 2. The same order of variables was used in logistic regressions to predict ART 
adherence ( <95% of the time or not) and clinical versus non-clinical levels of CD4 cell 
count (clinical = CD4 count of <500 cells/mm3). This hypothesis was not supported for 
any of the outcomes. However, PRD tended to inversely relate to viral load (log10 
transformed), controlling for PGD, f3 = -.43,p = .09 (see Table 3.11), but none of the 
discrimination variables related to detectable versus non-detectable viral load levels 
(detectable= >50 cp/mL). 
Depressive symptoms and quality of life. To test the hypothesis that PGD and 
PRD significantly relate to depressive symptoms and quality of life as continuous 
outcome variables, demographic and PD covariates were entered in the first step of 
hierarchical multiple linear regression, with PGD and PRD entered in step 2. Logistic 
regression was used to examine the relationships between PGD and PRD and depressive 
symptoms at above or below clinical levels, using two clinical cut-offs, 16 and 23 . The 
hypothesis was not supported for relationships of PGD and PRD with depressive 
symptoms and quality of life. However, when controlling for PGD, higher PRD tended to 
relate to lower depressive symptoms, f3 = -.45,p = .08 (see Table 3.12). When using the 
clinical cut-off scores of 16 and 23, and controlling for age and PD, neither PGD nor 
PRD significantly related to clinical levels of depressive symptoms. 
Cardiovascular risk factors. To test the hypothesis that PGD and PRD 
significantly related to cholesterol, HDL cholesterol, systolic and diastolic blood 
pressure, and BMI as continuous outcome variables, demographic covariates and PD 
were entered in the first step of hierarchical multiple linear regression, with PGD and 
PRD subsequently entered in step 2. Logistic regression was used to examine PGD and 
PRD in relation to the cigarette-smoking variable and to the other cardiovascular risk 
variables dichotomized at clinical cut-off scores. 
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The hypothesis that both PRD and PGD would significantly relate to 
cardiovascular risk factors was partially supported. Each was significantly related to 
blood pressure and cigarette smoking but not in the predicted direction for PGD. 
Controlling for age and PD, higher PGD significantly related to lower, fJ =-.57, p = .04, 
while higher PRD significantly related to higher diastolic blood pressure, fJ = .60, p = .02 
(see Table 3.13). However, when diastolic hypertension was the outcome, PGD was not a 
significant predictor but a one-unit increase in PRD was significantly associated with 
4.02 times greater likelihood, fJ = 1.39, p = .03, of having hypertensive levels of diastolic 
blood pressure (see Table 3.14). Controlling for age and PD, PGD tended to relate to 
lower systolic blood pressure, fJ = -.47,p = .08, and PRD significantly related higher 
systolic blood pressure, fJ = .70,p = .01 (see Table 3.15). Controlling for age, PD, PGD 
was significantly associated with a decreased likelihood of current smoking, fJ = -1.85, p 
= .04, odds ratio = .16, while PRD tended to relate to an increased likelihood of current 
smoking,,B = 1.19,p = .08, odds ratio= 3.28 (see Table 3.16). Neither POD norPRD 
were significantly related to BMI, cholesterol, and HDL cholesterol. 
These results should be interpreted cautiously because of high collinearity 
between PRD and PGD. The zero-order correlation, r = .89,p < .0001, and the partial 
correlation, controlling for PD, r = .81, p < .0001, between PGD and PRD were very 
high. However, tests for collinearity (tolerance and VIF statistics) were at acceptable 
levels for both PGD and PRD. The high overlapping variance might have produced the 
opposite directions of relationships with outcomes that are not reflective of each 
variable's relationships with outcomes (Thompson & Levine, 1997). 
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To explore the issue of possible error due to high collinearity, bivariate 
correlations between each predictor and the outcomes were examined. In partial 
correlations, controlling for PD and demographics, PRD was positively significantly 
related to systolic blood pressure, r = .25,p < .05, and positively but non-significantly 
related to diastolic blood pressure, r = .13, n.s., and to the increased likelihood of 
cigarette smoking, r = .05, n.s., (see Table 3.9). Partial correlations between PGD and 
blood pressure and smoking were small and not significant. Controlling for PD and 
demographics, PGD was associated with higher systolic blood pressure, r = .06, n.s., 
lower diastolic blood pressure, r = .05, n.s., and decreased likelihood of smoking, r = 
.12, n.s. Although the bivariate correlations were not significant, the directions of the 
relationships between PGD and PRD and the cardiovascular outcome variables were 
mostly consistent across bivariate and multivariate analyses, suggesting that the role of 
collinearity may not have affected the direction of the predictors in multivariate analyses. 
The exception was systolic blood pressure, which had a positive, but extremely small, 
non-significant bivariate association with PGD. 
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Alcohol and substance use. Hierarchical logistic regression analyses were used to 
examine the associations between PGD and PRD with dichotomous substance use 
outcome variables including current/former use versus never having used alcohol, 
cannabis, intravenous drugs, and crack, cocaine, or heroin (CCH) and current use of 
alcohol, crack, and cannabis. Controlling for age, PD, and PGD, higher PRD was 
significantly associated with increased likelihood of current/former (versus no 
current/former) use of cannabis, B = -3 .65, p = .047, odds ratio= .03, and CCH, B =-
2.45, p = .01 , odds ratio= .09. Controlling for age, PD, and PRD, higher PGD tended to 
relate to a decreased likelihood of current or former cannabis use, B = 3.05, p = .09, odds 
ratio= 21.18, and CCH, f3 = l.90, p = .09, odds ratio= 6.72 (see Tables 3.17 and 3.18). 
PGD and PRD did not significantly relate to use of alcohol or intravenous drugs, nor did 
they relate to current crack or cannabis use. Bivariate correlations were examined as done 
with cardiovascular health outcomes above in comparison with multivariate analyses. In 
partial correlations, controlling for PD and demographics (see Table 3.1 0), PRD was 
related to increased likelihood of current/former (vs. never) use of CCH, r = .24, p = .04, 
and cannabis, r = .24, p < .05. Controlling for PD and demographics, partial correlations 
with PGD were small and not significant, relating to increased likelihood of CCH, r = 
. 08, n.s., and cannabis, r = .13 , n.s. The directions of the relationships were consistent, 
therefore reducing the possibility that the results were due to high collinearity between 
PRD andPGD. 
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In summary, Hypothesis 1 was partially supported for several outcome variables. 
PGD and PRD were found to significantly relate to the cardiovascular risk factors of 
blood pressure and cigarette smoking but in opposite directions. PGD, when examined 
concurrently with PRD, was related to better cardiovascular health and health behavior, 
while PRD was associated with poorer cardiovascular health and health behavior. In 
addition, PGD and PRD also significantly related to substance use when examined 
simultaneously. PGD was found to be protective against use of illicit drugs, as it was 
significantly associated with an increased likelihood of having never used cannabis and a 
tendency to have never used CCH, while PRD was significantly related to an increased 
likelihood of current or former use of cannabis and CCH. 
Hypothesis 2. Hypothesis 2 predicted that in HIV-infected African-American 
women, DS would help explain the associations of PRD and PGD with markers of HIV 
disease, ART adherence, higher depressive symptoms, lower quality of life, 
cardiovascular risk, and substance use. To test hypothesis 2, hierarchical multiple linear 
and logistic regression analyses were used as described above, and DS was entered into a 
model in step 3. 
Markers ofHIV disease and ART adherence. Controlling for age, PD, PGD and 
PRD, DS tended to relate to higher CD4 cell count, fJ = .39,p = .07 (see Table 3.19). 
However, none ofthe discrimination variables was related to the likelihood of having a 
CD4 cell count above or below the clinical cut-off of 500 cells/mm3. DS was not 
significantly related to viral load as hypothesized. Adding DS to the model ofPRD, PGD 
and viral load (log10 transformed), the association between PRD and lower viral load 
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(log10 transformed) was strengthened and became significant, f3 = -.58,p = .04 (see Table 
3.11). Discrimination stress was not significantly related ART adherence. 
Depressive symptoms and quality of life. The hypothesis that DS would help 
explain associations ofPGD and PRD with depressive symptoms was not supported. 
However, unexpected results were found when DS was included in the model. The 
association of PRD and lower depressive symptoms was strengthened and became 
significantly associated, f3 = -.77,p = .004, and DS was significantly associated with 
higher, depressive symptoms, f3 = .61, p = .004, controlling for PD and PGD (see Table 
3 .12). When the clinical cut-off of 16 for clinical levels of depressive symptoms was the 
outcome, a similar pattern emerged. Controlling for PD and PGD, a one unit increase in 
PRD was significantly associated with a .28 times decrease in likelihood of clinical levels 
of depressive symptoms, f3 = -1.27, p = .03, odds ratio= .28, but a one-unit increase in 
DS was associated with a 2.53 times higher likelihood of clinical levels of depressive 
symptoms, f3 = .93, p = .02, odds ratio= 2.53 (see Table 3.20). Using a higher cut-off 
score of23, controlling for PD and PGD, for every one-unit increase in PRD, participants 
tended to be .31 times less likely to report severe clinical levels of depressive symptoms, 
f3 = -1.19, p = .07, odds ratio= .31, but for every one-unit increase in DS, participants 
were 2.33 times more likely to report severe clinical levels of depressive symptoms, f3 = 
.85, p = .03, odds ratio= 2.33 (see table 3.21). None ofthe discrimination variables 
significantly predicted quality oflife. 
Cardiovascular risk factors. The hypothesis that DS would significantly explain 
the positive association ofPGD and PRD with cardiovascular risk factors was not 
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supported. Relationships between PGD and PRD with diastolic blood pressure (BP) were 
unaffected after including DS in the model. Controlling for age and PD, DS was not 
associated with diastolic BP while PGD continued to be significantly associated with 
lower, fJ = -.56,p = .046, and PRD was significantly associated with higher, fJ = .61,p = 
.03, diastolic BP (see Table 3.13). When examining diastolic BP at hypertensive versus 
non-hypertensive levels, controlling for age and PD, neither DS nor PGD was 
significantly associated with diastolic hypertension but a one-unit increase in PRD was 
significantly associated with a 4.47 times higher likelihood of diastolic hypertension 
levels, fJ = .50, p = .04, odds ratio= 4.47 (see Table 3.14). The relationships between 
PGD and PRD with systolic BP were unaffected by the addition ofDS. DS did not 
significantly relate to systolic BP, and PGD tended to be associated with lower, fJ = -.48, 
p = .08, while PRD significantly related to higher, fJ = .67, p = .02, systolic blood 
pressure (see Table 3.15). None ofthe three discrimination variables was significantly 
related to systolic hypertension. Controlling for income and PD, when DS was included 
in the model, PRD no longer tended to relate, but PGD continued to significantly relate to 
decreased likelihood of current cigarette smoking, fJ = -1.91,p = .03, odds ratio= .15 
(see Table 3.16). DS, PGD, and PRD were not significantly related to BMI, cholesterol, 
or HDL cholesterol. 
Alcohol and substance use. The hypothesis that when added to the model, DS 
would significantly relate to and help to explain the relationships ofPGD and PRD with 
alcohol and substance use was not supported. DS did not influence the associations of 
current or former (versus no current/former) use of CCH or cannabis by PGD and PRD. 
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With DS in the model, PRD was no longer significantly associated, and PGD continued 
its tendency to relate to a higher likelihood of never having used cannabis, fJ = 3.58, p = 
.08, odds ratio= 35.75 (see Table 3.17). With DS in the model, PGD tended to relate to 
decreased,/]= 1.98, p = .07, odds ratio= 7.21, while PRD significantly related to 
increased, fJ = -2.45 , p = .01, odds ratio= .09, likelihood of current/former CCH (versus 
no current/former) CCH use (see Table 3.18). The discrimination variables were not 
significantly related to alcohol or other substance use. 
Aim 2. Aim 2 examined the direct effects, and the indirect effects when mediated 
by DS, ofPRD and PGD on HIV-related, psychological health, cardiovascular risk 
outcomes. 
Hypothesis 3. Hypothesis 3 predicted a path model (see Figure 3.1) in which PRD 
would have direct effects on DS (Path b) and on the dependent variable (Path a), PGD 
would have direct effects on DS (Path c) and on the dependent variable (Path d), and DS 
would have a direct effect on the dependent variable (Path e). PRD was hypothesized to 
also have an indirect effect on the dependent variable through its effects on DS (Path b x 
Path e). PGD was hypothesized to also have an indirect effect on the dependent variable 
through its effects on DS (Path c x Path e). Direct and indirect effects ofPGD, PRD, and 
DS were hypothesized to have the following effects on the continuous dependent 
variables: higher depressive symptoms, lower quality of life, higher cholesterol, lower 
HDL cholesterol, higher diastolic and systolic blood pressure, and lower viral load (log10-
transformed), and higher CD4 cell count. 
Path analysis, a type of regression analysis that estimates direct and indirect 
47 
causal relationships among variables, was used to test this hypothesis. In path analytic 
models, direct effects refer to the strength of the relationship between independent and 
dependent variables, controlling for other variables in the model. Indirect effects refer to 
the effect of an independent variable on a dependent variable as mediated through a third 
variable. Indirect effects are estimated by multiplying the coefficient between the 
predictor variable and the mediator variable by the coefficient between the mediator 
variable and the outcome variable. Coefficients were estimated using the MPlus program 
(Muthen & Muthen, 1998). Tests of goodness of model fit are not reported because there 
were zero degrees of freedom. 
The hypothesized path model fit only depressive symptoms. The standardized 
path coefficients with depressive symptoms as the dependent variable are presented in 
Figure 3.2. For all regressions, age and perceived discrimination were controlled. As 
predicted, there was a significant pathway from PRD to DS, and to depressive symptoms. 
Pathways from PGD to DS and to depressive symptoms were not significant. DS was 
significantly related to higher depressive symptoms. Table 3.21 summarizes regression 
equations used to construct the path model. PRD and PGD accounted for 71% of the 
variance in DS. PRD, PGD, and DS accounted for 20% of the variance in CES-D. 
Together, PRD, PGD, and DS accounted for 91% of the variance in depressive 
symptoms. 
Table 3.23 displays the direct and indirect effects ofPRD, PGD, and DS on 
depressive symptoms. PRD had significant direct and indirect effects (through DS) on 
depressive symptoms and PGD tended toward a direct effect on DS. While the significant 
48 
direct effect ofPRD on depressive symptoms was negative, the indirect effect ofPRD on 
depressive symptoms via DS was positive. The indirect effect ofPRD on depressive 
symptoms as mediated by DS reduced the total effect of PRD on depressive symptoms, a 
result of a suppression effect of DS. A suppressor effect occurs when a predictor that was 
not previously correlated with the outcome becomes a significant predictor with the 
addition of another predictor variable in the model. In zero-order correlation, DS was not 
significantly associated with depressive symptoms. However, when both PGD and PRD 
were included in the model, DS emerged as a significant positive predictor of depressive 
symptoms, indicating that DS was a suppressor variable. 
Aim 3. Aim 3 examined CC as a moderator of the effects ofPGD, PRD, and DS on 
psychological, cardiovascular risk, and alcohol and substance use outcomes. 
Means and standard deviations of CC total score and of the four dimensions of 
CC for HIV -infected women are displayed in Table 3 .1. Zero-order correlations among 
CC, discrimination variables, and outcome variables for HIV -infected women are 
displayed in Tables 3.6. 
Hypothesis 4. Hypothesis predicted that CC would be significantly positively 
related to PGD, PRD, and DS. As predicted, CC was significantly positively related to 
PGD, r = .36,p = .002, PRD, r = .44,p < .001, and DS, r = .37,p = .001. 
Hypothesis 5. Hypothesis 5 predicted that CC would significantly relate to higher 
education, income, and to employment. For HIV -infected women, CC was significantly 
related to higher education, r = .32, p = .01, and tended to relate to employment, r = .21 , 
p = .07. CC was not significantly related to income. 
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Hypothesis 6. Hypothesis 6 predicted that CC would significantly relate to better 
HIV-related health in terms ofhigher CD4 cell counts and lower viral load, lower 
depressive symptoms, higher quality of life, lower cardiovascular risk, and decreased 
likelihood of current or former substance use. Controlling for demographic variables, CC 
was significantly associated with current cannabis use, r = .26, p = .03, and higher CD4 
cell count, r = .27,p = .03, and tended to relate to lower depressive symptoms, r = .23,p 
= .06. CC was not significantly related to other outcomes. 
Hypothesis 7. Hypothesis 7 predicted that CC would moderate the relationship 
between DS and health outcomes so that at higher levels DS, participants endorsing lower 
levels of CC would have worse health outcomes and higher likelihood of substance abuse 
than participants with higher levels of CC and other combinations of CC and DS. A series 
of multiple linear regressions were performed for each continuous dependent variable: 
CD4 cell count, viral load (log10-transformed), depressive symptoms, quality of life, 
BMI, diastolic blood pressure, systolic blood pressure, cholesterol, HDL cholesterol, and 
alcohol use. A series oflogistic regressions were performed for each dichotomous 
outcome variable: current/former (versus no current/former) use of crack, cocaine, or 
heroin (CCH), intravenous drugs, cannabis, and alcohol, as well as current smoking and 
the continuous variables listed above that were dichotomized as above or below clinically 
meaningful cut-off scores. In step 1, age, education, and employment were entered as 
covariates; in step 2, DS and CC were entered, and in step 3, the interaction ofDS and 
CC were entered as predictor variables. 
Hypothesis 7 was supported for several outcomes. In linear regressions, CC was a 
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significant moderator of the relationship between DS and CD4 cell count, fJ = .36, p = 
.008 (see Table 3.24 for model summary), and DS and log10-transformed viral load, fJ =-
.26,p < .05 (see Table 3.25). CC was also a significant moderator ofDS at above or 
below CD4 cell counts of 500 cells/mm3, fJ = .13 ,p = .01 , but did not moderate DS and 
detectable versus non-detectable viral load. Following Holmbeck' s (2002) methods for 
probing significant interaction effects, post hoc regressions were used to compute simple 
slopes of the conditional effects ofDS on CD4 cell count and viral load for participants 
with high (1 SD above the mean) and low (1 SD below the mean) levels of CC. As 
displayed in Figure 3.3 , DS was positively related to CD4 cell count for participants who 
endorsed higher CC, with a significant slope, fJ = .36, p = .01. In contrast, DS was 
negatively associated with CD4 count for participants endorsing lower CC, with a non-
significant slope, fJ = -.29, p = .15. When the outcome was above or below 500 cells/mm3 
CD4 count, at higher DS, higher CC predicted greater likelihood of CD4 count below 500 
cells/mm3 (see Table 3.26). For the prediction of viral load (log10-transformed), Figure 
3.4 shows the tendency toward a positive slope ofDS and viral load (log10-transformed) 
for participants endorsing lower levels ofCC, B = .41,p = .06, in contrast to the non-
significant negative slope ofDS and viral load (loglO-transformed) for participants 
endorsing higher levels of CC, B = -.26, p = .11 . CC did not significantly moderate the 
relationship between DS and any of the other dependent variables . 
Hypothesis 8. Hypothesis 8 predicted that CC would moderate the relationship 
between PGD and health outcomes so that at higher levels ofPGD, participants with 
lower levels of CC would have worse health outcomes than participants endorsing higher 
CC and other combinations ofCC and PGD. A series oflinear and logistic regressions 
were performed with dependent variables as described above. 
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CC significantly moderated the relationship between PGD and CD4 cell count, B 
= .41,p = .001 (see Table 3.27 for model summary). Figure 3.5 shows that for 
participants endorsing high CC, PGD was significantly positively related to CD4 count, fJ 
= .41, p = . 003. For participants endorsing low CC, the association between PGD and 
CD4 count was negative and not significant, fJ = -.29, p = .1 0. CC was also a significant 
moderator ofthe relationship between PGD and clinically significant levels of CD4 cell 
count, fJ = -.18 p = .01, such that for women with higher CC, higher PGD was related to 
higher likelihood of a CD4 cell count of 500 or higher while for women with lower CC, 
higher PGD was related to lower likelihood of CD4 cell of 500 (see Table 3 .28). CC 
tended to moderate the relationship between PGD and viral load (log10-transformed), fJ = 
-.04,p = .09 (see Table 3.29), such that at higher CC, higher PGD was associated with 
lower log10-transformed viral load (see Figure 3.6). However CC significantly moderated 
the relationship between PGD and detectable levels of viral load, fJ = -.11 p = . 04 (see 
Table 3.30). For women with higher CC, higher PGD was associated with lower 
likelihood ofhaving detectable levels of viral load while women for lower CC, higher 
PGD was associated with higher likelihood of having detectable levels of viral load. The 
interaction ofPGD and CC did not significantly predict any other outcome variables. 
Hypothesis 9. Hypothesis 9 predicted that CC would moderate the relationship 
between PRD and health outcomes and substance use so that at higher levels ofDS, 
participants endorsing lower CC, higher PRD would relate to worse health outcomes and 
decreased likelihood of substance use compared with participants with higher CC and 
other combinations ofCC and PRD. A series oflinear and logistic regressions were 
performed with dependent variables as described above. 
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CC significantly moderated the relationship between PRD and CD4 cell count, f3 
= .42,p = .001 (see Table 3.31 for model summary). Figure 3.7 shows that for 
participants endorsing high CC, there was a significant positive association between PRD 
and CD4 count, f3 = .36, p = .01. For participants endorsing low levels of CC, there was a 
significant negative association between PRD and CD4 count, f3 = -.42, p = .04. CC was 
also a significant moderator ofPRD when examining CD4 count at clinical versus non-
clinical levels, f3 = .14, p = .01 (see Table 3.32), so that for participants with higher CC, 
higher PRD was associated with higher likelihood of CD4 cell count of 500 or higher. 
When examining viral load at detectable versus not detectable levels, CC significantly 
moderated its relationship with PRD, f3 = -.11,p = .03, such that higher PRD was 
associated with greater likelihood of non-detectable viral load for participants with higher 
CC and with a greater likelihood of detectable viral levels for participants with lower CC 
(see Table 3.33 for final model summary and Figure 3.8). The interaction ofPRD and CC 
did not significantly predict any other outcome variables. 
Hypothesis 10. Hypothesis 10 predicted that collective action orientation (CAO), 
a dimension of CC, would moderate the relationship between DS and health and 
substance use outcomes such that at higher levels ofDS, lower CAO would relate to 
worse outcomes than higher CAO and other combinations ofDS and CAO. A series of 
linear and logistic regressions were perfonned with outcome variables as described 
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above, examining the effects ofDS on outcomes as moderated by CAO. 
CAO and DS interacted to significantly predict quality of life (QOL), ~ = .30, p = 
.01, and alcohol use, B = -.30, p = .02 (see Tables 3.33 and 3.34 respectively, for model 
summaries). As shown in Figure 3.9, for participants endorsing low CAO, DS was 
negatively associated with QOL, with a significant slope, B = -.40, p = .02, but for 
participants endorsing high CAO, DS was non-significantly positively associated with 
QOL, B = .41 , p = .67. Figure 3.10 shows the significant positive slope between DS and 
heavy alcohol use, B = .46, p = .008, for participants who endorsed low CAO while for 
participants endorsing high CAO, there was a non-significant negative association 
between DS and heavy alcohol use, B = -.08,p = .61. 
Aim 4. Aim 4 sought to examine differences between HIV -infected and matched 
samples of HIV -uninfected African-American women on PGD, PRD, DS, and CC, as 
well as depressive symptoms, quality of life, cardiovascular risk, and substance use. A 
secondary aim was to explore HIV status differences in the patterns of relationships 
among predictor and outcome variables, but this aim could not be investigated because 
the small HIV-uninfected sample size precluded reliable between-group multivariate 
analyses. 
HIV-infected and HIV-uninfected Group Differences. Means and standard 
deviations for PGD, PRD, DS, and CC for the entire sample and by HIV status are 
displayed in Table 3 .1. No significant differences in PRD, PGD, or DS were found by 
HIV status. For the entire sample, the mean for PRD was 2.19 (SD = .97), the mean for 
PGD was 1.96 (SD = .74), and the mean forDS was 2.32 (SD = 1.11). There were no 
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differences in total CC scores by HIV status. Mean scores of each CC dimension for the 
entire sample were 3.47 (SD = .99) for identification, 4.23 (SD = .49) for power 
discontent, 3.25 (SD = .89) for rejection of system legitimacy, and 3.68 (SD = .65) for 
collective action orientation. However, a difference by HIV status was found in an 
indicator of CC; uninfected women endorsed greater belief in the need for social change 
on behalf of African Americans (M = 4.38, SD = .71) than HIV infected women (M = 
3.82, SD = 1.09; t(94) = 2.33, p = ). 
Means and standard deviations of continuous outcome variables for the entire 
sample and for each HIV status group are displayed in Table 3.2. HIV-infected women 
scored significantly higher on depressive symptoms on the CES-D (M = 15.16, SD = 
1 0.89) and lower on quality of life (M = 68.68, SD = 15.06) than uninfected women (M = 
9.20, SD = 7.88; f3 = .25,p = .02 and M= 80.59, SD = 15.06; f3 = -.22,p = .03 , 
respectively). HIV -infected women had significantly lower HDL cholesterol levels (M = 
52.29, SD = 16.64) than uninfected women (M= 59.96, SD = 16.68; f3 = -.23,p = .02) but 
also tended to have lower total cholesterol (M = 164.45, SD = 44.28) than uninfected 
women (M = 180.80, SD = 30.74; f3 = -.19, p = .07). 
Tables 3.3 and 3.4 display the frequencies and percentages of participants scoring 
above and below clinically meaningful cut-offs for the entire sample and by HIV status 
for the continuous variables above (with the exception of quality oflife) that were 
dichotomized at clinically meaningful cut-off scores. The Fisher's exact text revealed that 
at a cut-off of 16, the percentage ofHIV-infected women (41 %) with clinical levels of 
depressive symptoms was significantly greater than HIV-uninfected women (16%),p = 
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.03. At the more stringent CES-D cut-off of23, there was a tendency for a greater 
percentage ofHIV-infected women (25%) to have severe levels of depressive symptoms 
than HIV-uninfected women (8%),p = .10. A greater percentage ofHIV-uninfected 
women (80%) tended to be overweight or obese (BMI of 25 or above) compared to HIV-
infected women (57.5%; x2 = 3.14,p = .08). No differences were found by HIV status for 
dichotomized cholesterol, HDL cholesterol, and diastolic and systolic blood pressure 
variables. Eighty percent of the entire sample (n = 78) had cholesterol levels below the 
200 cut-off point for high cholesterol and systolic blood pressure at or below the 
hypertensive level of 140 and 76.5% had diastolic blood pressure at or below the 
hypertensive level of 90, and 72.5% had HDL cholesterol levels below 40. A greater 
proportion ofHIV-uninfected women tended to report never having used cannabis (32%) 
compared with HIV-infected women (13.7%; i= 3.03 , p = .08). 
Aim 5. Aim 5 sought to examine relationships among incarceration, PGD, PRD, 
DS, CC, substance use, and health and health behavior outcomes. Hypotheses were not 
made due to the exploratory nature of these analyses. No differences in rates of 
incarceration were found by HIV status. All analyses examined included both HIV-
infected and HIV-uninfected women . 
. Fifty-one percent of women in the entire sample had a history of at least one 
incarceration. Forty-eight percent ofHIV-infected and 52% ofHIV-uninfected women 
had a history of incarceration. Of the women who had ever been incarcerated, 66.7% had 
been incarcerated more than once. Twenty-three percent were incarcerated twice and 
15% were incarcerated three times. 
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Zero-order correlations (see Table 3.36) showed that incarceration was 
significantly associated with unemployment, r = .21,p = .04 and tended to be associated 
with older age, r = .20,p = .05. Because age was significantly related to PRD, PGD, and 
DS and tended to differ by HIV status, partial correlations controlling for age were 
performed. Tables 3.37 and 3.38 display partial correlations between predictor variables 
and incarceration and between outcome variables and incarceration, respectively. 
Controlling for age, incarceration significantly related to higher PRD, r = .22,p = .03, 
and tended to relate to PGD, r = .18,p = .08. Controlling for age, incarceration related to 
current cannabis use, r = .21, p = .04, current/former use of CCH, r = .52, p < .001. A 
history of incarceration was significantly related to higher systolic, r = .27, p = .008, and 
diastolic, r = .35,p < .001, blood pressure and lower depressive symptoms, r = .21,p = 
04. Controlling for age, partial correlations showed that frequency of incarceration was 
significantly related to higher power discontent, r = .38,p = .01, and tended relate to 
higher rejection of system legitimacy, r = .28,p = .06, and total CC, r = .27,p = .07. 
Critical consciousness, discrimination, substance use, and incarceration. To 
examine associations between PGD, PRD, CC, alcohol and substance with incarceration, 
multiple logistic regression analyses were performed, controlling for age and education. 
In multiple regressions examining the associations between CC and each substance and 
alcohol use variable and incarceration, it was found that current cannabis use, B = -1.52, 
p = .02, odds ratio= .22, and CCH, B = -3.94,p < .001, odds ratio= .02, significantly 
related to a higher likelihood of incarceration, but CC did not relate to incarceration in 
either model (see Table 3.39). CC did not significantly relate to incarceration in any of 
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the models. When examining the associations of PGD and alcohol and substance use 
variables on the likelihood of incarceration, current/former (versus no) CCH use, (B =-
3.72,p < .001, odds ratio= .02), and current cannabis use, (B = -1.58,p = .02, odds ratio 
= .21 ), significantly related to a higher likelihood of incarceration while PGD was not 
significantly related to incarceration. When alcohol and PGD were examined together, 
PGD significantly predicted higher likelihood of incarceration, B = .68, p = .04, odds 
ratio = 1.98, while alcohol was not related to incarceration (see Table 3 .40). Finally, the 
associations of PRD and alcohol and substance use variables on the likelihood of 
incarceration were examined (see table 3.41 for four model summaries). Current/former 
use ofCCH, B = -3.66, p = .001, odds ratio= .03, and current cannabis use, B = -l.69,p 
= . 01, odds ratio = .18, significantly related to incarceration while PRD was not 
significantly related to likelihood of incarceration. PRD significantly related to a greater 
likelihood of incarceration when examined with intravenous drug use, B = .46,p = .047, 
odds ratio= 1.59, and heavier drinking, B = .58,p = .02, odds ratio= 1.78, while the 
alcohol and substance variables did not significantly relate to likelihood of incarceration. 
Finally, associations of discrimination-related stress and alcohol and substance use were 
examined with likelihood of incarceration. Current/former CCH use significantly related 
to higher likelihood of incarceration, B = -3 .73,p < .001, odds ratio= .02 but DS did not. 
However, DS tended to relate to higher likelihood of incarceration, B = .40, p = .05, odds 
ratio= 1.49, when current/former (versus no current/former) alcohol use did not. Current 
cannabis use significantly related, B = -1.65, p = .01, odds ratio= .19, and DS tended to 
relate, B = .38,p = .07, odds ratio= 1.46, to higher likelihood of incarceration. 
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Interaction effects on incarceration. CC, PRD, PGD, and DS were also 
examined as moderators of alcohol and substance use and likelihood of incarceration in 
logistic regression. None of the interaction terms significantly predicted likelihood of 
incarceration; the relationships between alcohol and substance use and the likelihood of 
incarceration did not vary by participants ' levels of CC, PGD, PRD, and DS. 
Using hierarchical regression analyses, depressive symptoms and blood pressure 
were regressed on the critical consciousness and incarceration and their interaction term. 
CC and incarceration interacted to significantly predict depressive symptoms, f3 = -. 74, p 
= .03 (see Table 3.42). As displayed in Figure 3.11 , for participants with an incarceration 
history, CC was significantly negatively associated with depressive symptoms, f3 = -.51 , p 
< .001 , and with a significantly decreased likelihood of clinical levels of depression, f3 =-
.12,p = .02, odds ratio= .89 (see Figure 3.12). For participants without an incarceration 
history, depressive symptoms, f3 = .04, n.s., and clinical levels of depressive symptoms, f3 
= 0, n.s., did not vary as a function of CC. The result of regression analysis testing a 
three-way interaction term of Incarceration x CC x HIV status to investigate differences 
by HIV status was non-significant. The CC x Incarceration interaction did not 
significantly predict blood pressure. 
CCH as a mediator of PRD and incarceration. Mediation analyses were 
performed to examine current/former (versus no current/former) CCH use as a mediator 
of the relationship between higher PRD and higher likelihood of incarceration. Baron and 
Kenny' s (1986) four conditions for performing mediation were followed: There must be a 
significant association between (1) the predictor (PRD) and the criterion variable 
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(incarceration), (2) the predictor and the mediator variable, (3) the mediator and the 
criterion variable, and 4) in an equation including the predictor (PRD) and the mediator 
(CCH), the relationship between the predictor and the outcome decreases when the 
mediator is in the analysis. If the direct effect approaches zero, the mediator can be said 
to fully account for the relationship between predictor and outcome (Baron & Kem1y, 
1986). 
A series of logistic regressions were used to test CCH as a mediator of the 
relationship between PRD and incarceration, controlling for age and education in all 
analyses. Meeting the first condition of Baron & Kenny (1984), the predictor variable 
(PRD) was significantly related to the outcome incarceration, f3 = .54, p = .02. The 
second condition, that the predictor (PRD) is significantly related to the mediator (CCH), 
was also met, f3 = -. 7 6, p = . 02. The third condition, that the mediator ( CCH) is 
significantly related to the outcome variable (incarceration) when included in the model 
with the predictor, was also met, f3 = -3.63,p = .001. When the mediator was included 
with the predictor variable, the coefficient of the predictor variables was reduced and no 
longer significantly predicted incarceration, f3 = .29, n.s. These results are consistent with 
partial mediation. 
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CHAPTER FOUR 
Discussion 
The present research contributes to the literature on how critical consciousness 
(CC), perceived racial and gender discrimination (PRD and PGD), discrimination-related 
stress (DS), and incarceration are associated with health behaviors and outcomes in 
African-American women with and at risk for HIV. The study indicates that CC, and in 
particular its collective action orientation (CAO) dimension, is an adaptive coping 
strategy. In African American HIV-infected women, CC was significantly related to 
markers ofbetter HIV health in the context ofPRD, PGD, and DS and to lower 
depressive symptoms, higher CD4 cell count; CAO was significantly related to higher 
quality of life and lower alcohol use in the context of high DS. For both HIV-infected and 
uninfected women, CC was related to higher PRD, PGD, and DS and to lower depressive 
symptoms in the context of an incarceration history. 
The present study adds new perspectives on the complexity of the relationships of 
PRD, PGD, and DS with different health behaviors and outcomes, with racial and gender 
discrimination sometimes being protective factors for better health and at other times risk 
factors for worse health. Although some of these results supported hypotheses about the 
negative effects of PGD and PRD on health outcomes, other results were significant in 
directions opposite to predictions. For example, PRD significantly related to higher, 
while PGD related to lower, diastolic and systolic blood pressures, likelihood of smoking, 
and current/former (versus no current/former) use of marijuana and CCH. Considering 
PGD and PRD together with DS strengthened the relationships between PRD and some 
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health outcomes and revealed indirect effects ofDS between PRD and higher depressive 
symptoms. 
Finally, the present research adds to our understanding how incarceration relates 
to PGD, PRD, DS, CC, health, and substance use in both HIV-infected and uninfected 
women and how these variables differ by HIV status. Although no specific hypotheses 
had been generated about these relationships, the results indicated that women with HIV 
in comparison to those without HIV did not differ in levels ofPGD, PRD, DS, and CC 
with the exception of one indicator of CC in which HIV -infected women endorsed 
greater beliefs about the need for social change on behalf of African Americans. 
However, health differences were found by HIV status, with HIV -infected women having 
significantly higher depressive symptoms and HDL cholesterol and lower quality of life. 
Women did not differ by HIV status in history of incarceration, with 51% of the entire 
sample having a history of at least one incarceration. Exploratory investigations of 
relationships between incarceration and discrimination, CC, and health revealed that 
incarceration significantly related to higher PRD, current/former use of marijuana and 
CCH, higher blood pressure, and lower depressive symptoms and tended to relate to 
higher PGD and CC. CCH was also found to partially mediate the positive relationship 
between PRD and incarceration. In the following sections, these results will be discussed 
in detail in the context of empirical and theoretical literature. 
Discrimination, Critical Consciousness, and Health 
Higher levels of CC were found to relate to higher levels of education and 
employment, higher CD4 cell count, current/former marijuana use, and lower depressive 
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symptoms in HIV-infected African-American women. CC was also found to be a 
protective factor against PGD, PRD, and DS with HIV disease markers. The collective 
action orientation dimension of CC specifically was found to be a protective factor with 
quality oflife and alcohol use at high levels ofDS. 
Consistent with previous research (Zucker et al., 2005), education and 
employment were significantly associated with higher CC in the present study, showing 
that these capital resources also relate to CC in African-American women with and at risk 
for HIV. CC was also significantly related to higher PRD, PGD, and DS. Awareness of 
inequitable sociopolitical systems may promote higher perceptions of discrimination and 
experiences of discrimination-related stress as proximal manifestations of inequality 
(Brown & Johnson, 1999). However, it is also possible that the direction of causality is 
reversed, that is, that being treated in discriminatory ways promotes the development of 
critical consciousness. For example, previous research has indicated that African 
Americans who reported personal experiences with discrimination were more likely to 
attribute causes of the disproportionate incarceration of African-American men to 
structural factors such as fewer job opportunities and failure of school systems to serve 
African-American men than were African Americans who did not report experiences 
with racial discrimination (Unnever, 2008). 
After controlling for demographics, CC was significantly related to current 
marijuana use, higher CD4 cell count, and lower depressive symptoms. It is possible that 
individuals who are aware of social injustices are drawn to participate in peer groups that 
use marijuana as a rebellion against the social status quo, since marijuana use is illegal 
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but has a reputation as being equal to or even less threatening in its health consequences 
than alcohol, which is legal, and both have been found to be socially acceptable (Arbour-
Nicitopoulos, Kwan, Lowe, Taman, & Faulkner, 2011). In addition, research indicates 
that in youth, identification with less conventional social groups was significantly related 
to higher likelihood of marijuana use compared to more conventional social groups 
(Verkooijen, de Vries, & Nielsen, 2007). The relationship found between CC and lower 
depressive symptoms and to higher CD4 cell count may be due to the function of critical 
consciousness as a coping strategy that externalizes the attribution for discrimination and 
other potentially stressful effects of belonging to subordinated groups in society (Crocker 
& Major, 1989). Externalization may be more adaptive than alternative strategies such as 
internalization and self-blame. The empowerment and social action that is theorized to be 
associated with critical consciousness may also promote behaviors that facilitate better 
health. However, the explanation for the direction of effects between CC and marijuana 
use, depressive symptoms, and CD4 cell counts may also be the reverse: Marijuana use, 
being less depressed, and being healthier in the form of having higher CD4 cell counts 
may enhance awareness of social inequities. Lower depressive symptoms and better 
health may allow for greater cognitive, social, and behavioral engagement that facilitates 
understanding structural forces in society (Gotlib & Joormann, 2010). 
In the present study, CC moderated the relationships between discrimination and 
HIV-related health in HIV-infected women. Women with high critical consciousness had 
higher levels of CD4 cell count and lower likelihood of detectable viral load when 
reporting high PGD, PRD, and DS compared with women with low critical 
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consciousness. These data suggest that, in the context of high PGD, PRD, and DS, high 
CC was a protective, while low CC was a risk factor in HIV health for African-American 
women with HIV. Few studies have investigated critical consciousness as a buffer of the 
harmful effects of discrimination on health. The studies that do exist focus on system-
blame, a dimension of CC, and are in line with the present findings in that system blame 
has been found to relate to better physical and psychological health outcomes than self-
blame. For example, one longitudinal study of the relationship between racism and 
mortality found that system blame (external attributional orientation), compared with 
self-blame (internal attributional orientation), promoted long-term survival in African 
Americans (LaVeist, Sellers, & Neighbors, 2001). When reporting experiences with 
racism, African Americans with an external attributional orientation were more likely to 
survive the 13-year follow-up period than those with an internal attributional orientation 
who did not report experiences with racism. A system-blame 01ientation was also found 
to buffer goal-striving stress and psychological well-being in college-educated African-
American men (Sellers, Neighbors, & Bonham, 2011). Previous literature has also shown 
that identification with one's oppressed group, another dimension of critical 
consciousness, moderated the relationship between discrimination and psychological 
adjustment (Jones, Cross, & DeFour, 2007; Branscombe, Schmitt, & Harvey, 1999). An 
alternative explanation for these results is that better HIV -related health is associated with 
the ability to perceive discrimination, which in tum, may contribute to the development 
of critical consciousness. 
The collective action orientation (CAO) dimension of critical consciousness was 
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examined independently as a buffer against poorer outcomes because joining with others 
to engage in social change is a central goal of critical consciousness (Friere, 1973). It was 
found that women with lower collective action orientation reported significantly lower 
quality of life and heavier drinking at high levels of reported DS in comparison with 
women with high collective action orientation. Higher collective action orientation may 
relate to higher quality of life because the social aspect of this orientation may provide 
social support, community cohesion, and hope for change when experiencing high levels 
of discrimination-related stress (Ajrouch, Reisine, Lim, Sohn, & Ismail, 201 0; Cowdery 
& Pesa, 2002; Lewin, Mitchell, Rasmussen, Sanders-Phillips, & Joseph, 2011). The 
social aspect of CAO may also help explain the association between lower CAO and 
heavier drinking at high levels ofDS, as few social supports have been associated with 
substance abuse (Staton-Tindall, Royse, & Leukfeld, 2007). A supportive social 
environment in which members are open to frank discussion has been shown to facilitate 
critical consciousness, although a direct link to action has not been explored (Kearney, 
2006). The present results suggest that higher CAO may be a buffer against heavy 
drinking and promote higher quality of life at high levels ofDS. 
In summary, critical consciousness was found to have protective effects on HIV-
related health and depressive symptoms for African-American women with and at risk for 
HIV. Having a high collective action orientation in particular, was found to relate to 
lower alcohol use and higher quality of life. These results provide initial empirical 
evidence for CC as a coping strategy that may be useful to promote in HIV prevention 
and intervention programs to improve HIV and psychological health. In addition, 
66 
promoting the acquisition of capital resources may also be useful in the development of 
CC. The awareness of gender and racial discrimination and discrimination-related stress 
may be indicators of CC since higher PGD, PRD, and DS were related to higher CC. The 
ability to perceive gender and/or racial discrimination may reflect a growing critical 
consciousness of the structural inequalities that promote discriminatory behavior against 
socially oppressed groups. On the other hand, perceptions of discrimination would be 
viewed as one of the manifestations of social inequity if one were critically conscious of 
structural factors in social life. The nature of relationships between perceptions of 
discrimination, discrimination-related stress and awareness of social inequality needs 
further examination in future research. 
Perceived Gender (PGD) and Racial Discrimination (PRD), Discrimination-related 
Stress (DS), and Health 
PGD, PRD, DS, Cardiovascular Risk, and Substance Use. In HIV-infected 
African-American women, PRD significantly related or tended to relate to higher, while 
PGD significantly related or tended to relate to lower, blood pressure, likelihood of 
smoking, and current/former (versus no current/former) use of marijuana and CCH. 
These results suggest that when examining the effects ofPRD and PGD concurrently, 
attributing experiences of discrimination to gender may be protective against 
cardiovascular risk (i.e. higher blood pressure and cigarette smoking) and substance use, 
while attributing perceptions of discrimination to race increases cardiovascular risk and 
likelihood of current or former substance use. These surprising and contradictory 
relationships of PGD and PRD to cardiovascular risk and substance use are the first to 
suggest that attributions to gender for discrimination may be protective. These results 
stand in contrast to previous research showing that higher POD related to higher 
likelihood of illicit drug use and smoking in women (Landrine et al., 1995; Ro & Choi, 
2012; Zucker & Zandry, 2007). 
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The current fmdings on PRD support previous research that found higher PRD to 
relate higher blood pressure/ hypertension (Peters, Benkert, Dinardo, & Templin, 2007; 
Williams & Neighbors, 2001), cigarette smoking (Bennett et al., 2005; Guthrie et al., 
2002) and substance use (Borrell et al., 2007; Gibbons et al., 2012) in African Americans. 
Relative to POD, it may be that PRD contributed to greater stress (perhaps that may not 
be explicitly known to the individual) on physical health and to using substance use as a 
coping strategy in the context of continuing systematic disempowerment in the U.S . for 
African Americans (Alexander, 2010). These interpretations are supported by much of 
the literature on PRD and adverse health and health behaviors (Bennett et al., 2005; 
Borrell et al. , 2007; Gibbons et al., 2012; Guthrie et al., 2002; Peters et al., 2007; 
Williams & Neighbors, 2001). 
It is important to note that the significant, or trends in, opposing relationships 
between PRD and POD with blood pressure, smoking, current/former cannabis and CCH 
use found in the present research emerged only when examining them simultaneously. It 
may be that for African-American women with HIV, attribution of discrimination to 
gender may reflect identification with a larger social group that can be psychologically 
protective (Schmitt & Branscombe, 2002). Identifying as a woman may reflect 
identification with a higher status in-group than identifying as African American (Tajfel 
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& Turner, 1986). The present results suggest the protective effect of such identification 
may extend to physical health and health behaviors. While it may be exceedingly difficult 
to parse different aspects oflived social identities, when examined separately and 
concurrently, it appears that attributions to gender for discrimination may contribute to 
greater empowerment that translates to better cardiovascular health and health behaviors. 
This by no means suggests that PGD is a positive feature of social life for African-
American women, but that PGD in this sample may reflect awareness of a reality that 
tended to relate to better cardiovascular health and health behavior. 
No studies to date have examined the concurrent effects ofPGD and PRD on 
cardiovascular risk and substance use in African-American women with HIV, so the 
current study provides a new perspective on the contributions of these variables, when 
examined together, to health and substance use outcomes. However, some caution should 
be taken in the interpretation of these results considering the high collinearity of PGD and 
PRD. Replication of these findings is needed. Alternatively, these results may 
demonstrate a suppressor effect such that the protective effects of PGD on blood 
pressure, likelihood of cigarette smoking and substance use may have been suppressed 
when the effects of PRD were not controlled. 
The inclusion of discrimination-related stress (DS) in regression models did not 
affect the associations of PGD and PRD with blood pressure, cigarette smoking, 
marijuana and CCH use. Patterns of relationships between PGD and PRD and 
cardiovascular health outcomes and substance use were similar to those without DS in the 
model. PRD continued to be associated with higher blood pressure and increased 
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likelihood of substance use while PGD continued to be associated with lower blood 
pressure and decreased likelihood of substance use. These results are in contrast to the 
few studies that measured both DS and perceived discrimination that showed DS was 
significantly related to hypertension but PRD was not (Davis, Liu, Quarells, & Din-
Dzietham, 2005), and that DS has also been found to mediate the relationships between 
PGD and cigarette smoking and illicit drug use (Ro & Choi, 2010; Zucker & Landry, 
2007). Many studies that did not measure DS have found significant direct relationships 
between PRD and PGD with poorer health outcomes (Bennett et al., 2005 ; Borrell et al. , 
2007; Gibbons et al. , 2012; Guthrie et al., 2002; Landrine et al. , 1995; Peters et al. , 2007; 
Ro & Choi, 2012; Williams & Neighbors, 2001; Zucker & Zandry, 2007). These 
differences between previous research and the results of the current study in the effects of 
different types of discrimination and of discrimination-related stress on health may be 
due to issues such as measurement of the constructs, social acceptability of reporting 
discrimination and/or stress, or the constellation of discrimination variables that are 
examined simultaneously (Williams & Mohammed, 2003). 
PGD, PRD, DS, Depressive Symptoms and HIV Disease Markers. The present 
study found that, in HIV-infected women, PRD tended to predict lower depressive 
symptoms when controlling for PGD, and that when also examining DS along with PRD 
and PGD, DS was significantly associated with higher, while PRD significantly related to 
lower, depressive symptoms. It was also found that PRD directly related to lower 
depressive symptoms but indirectly related to higher depressive symptoms; PRD related 
to higher DS and DS, in turn, was related to higher depressive symptoms. In contrast, 
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PGD tended to relate to higher DS but was not directly related to depressive symptoms. 
This inverse relationship between PRD and depressive symptoms differs from previous 
research showing positive associations between PRD and depressive symptoms (Brody et 
al., 2006; Jones, Cross, & DeFour, 2007; Lewin, Mitchell, Rasmussen, Sanders-Phillips, 
& Joseph, 2011). One exception was found in a recent study ofHIV-infected Black men 
who have sex with men, in which PRD was related to lower depressive symptoms when 
perceptions ofHIV and sexual orientation discrimination were low (Bogart et al., 2011). 
Similar to the protective relationship of CC and lower depressive symptoms 
discussed earlier, for members of socially stigmatized groups (i.e. women, minorities), 
attributing unfair treatment to racial discrimination may be a protective coping strategy 
that enables individuals to explain negative treatment by others as racism instead of 
explaining it by looking to personal causes (Crocker & Major, 1989). This coping 
strategy has been linked to lower depression and higher self-esteem in women and 
African Americans (Crocker, Voelkl, Testa, & Major, 1991). Attributions of perceived 
discrimination to prejudice against members of a particular social group differs from 
attributions to internal and stable aspects of self (i.e. "personal deservingness" 
attributions) and has been found to lead to less self-blame and depressed mood (Major, 
Kaiser, & McCoy, 2003). The lack of a significant relationship between PGD and 
depressive symptoms in the current sample is in contrast to previous research (Landrine 
& Klonoff, 1996; Landry & Mercurio, 2009; Moradi & Subich, 2003; Szymanski & 
Stewart, 201 0; Greer, 2011) and might be due to a variety of factors. Perhaps in relation 
to depressive symptoms, the salience of race in the social construction of identity 
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accounted for effects of gender discrimination in African-American women with HIV. In 
other words, the awareness of racial discrimination may have accounted for the much of 
the variance in depressive symptoms, possibly because in relation to depressive 
symptoms, African-American women may not have defined gender independently from 
race (Woods-Giscombe, & Lobel, 2008). In addition, attributions to race for 
discrimination among women living among a predominantly African American 
community may be more empowering and therefore contribute to lower depressive 
symptoms. Finally, the nature of the effects of multiple types of discrimination on 
psychological health is very complex, as demonstrated by the inconclusive results of 
previous research on African-American women examining the concurrent effects of PGD 
and PRD on psychological health outcomes (Canady et al., 2008; Greer, 2011; King, 
2005 ; Moradi & Subich, 2003; Remedios et al., 2011; Szymanski & Stewart, 2010; 
Thomas et al. , 2008). 
The significant indirect positive relationship ofPRD and depressive symptoms 
mediated by DS suggests that the appraisal of stress in response to perceived 
discrimination, rather the perception of racial discrimination itself, was related to higher 
depressive symptoms. The present data also showed a tendency for PGD to relate to 
higher DS but to not directly relate to depressive symptoms. While the lack of 
relationship between PGD and depressive symptoms is in contrast to previous research 
(Canaday et al., 2008), significant positive associations between PRD and higher DS 
(King, 2005) and between higher DS and higher depressive symptoms (Huynh, Devos, & 
Dunbar, 2012) have been previously found. 
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The present study also found that PRD tended to predict lower viral load in HIV-
infected women when controlling for PGD, and that when adding DS to the model with 
PRD and PGD, DS was not significantly associated, but PRD became significantly 
related to lower viral load. It was also found that DS tended to relate to higher CD4 cell 
count when controlling for PGD and PRD. These results suggest that PRD and DS may 
relate to markers of better HIV health, and are in contrast to the current significant 
positive relationships found between PRD and cardiovascular risk factors and substance 
use, but consistent with the inverse relationship found between PRD and depressive 
symptoms. No other studies to date have investigated perceived discrimination in relation 
to HIV disease markers. Previous research has found that PRD was related to poorer HIV 
health outcomes. For example, PRD was found to significantly relate to greater self-
reported AIDS-related symptom severity in HIV -infected individuals (Bird et al., 2004) 
and to lower ART adherence in a longitudinal study ofHIV-infected men who have sex 
with men (MSM; Bogart, Wagner, Galvan, & Klein, 2010). Thus, the relationship found 
in the present study between PRD and viral load was in contrast to what would be 
expected. Similarly to its relationship to lower depressive symptoms, the externalized 
attribution for discrimination to race may be a protective factor in viral load. The 
relationship between DS and higher CD4 cell count found in the current study is not 
easily explainable as a physiological response to stress. Acute stress activates the immune 
response, which increases CD4 cells (Dhabhar at al., 2010). However, discrimination-
related stress is a chronic stressor, resulting from an accumulation of everyday 
discrimination, and therefore not likely to produce a short-term increase in CD4 cells. 
Perhaps the very ability to endorse and recognize stress related to discrimination has 
benefits for immune functioning. 
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In summary, the results of the current investigation demonstrated complex 
relationships between multiple types of perceived discrimination and discrimination-
related stress and cardiovascular risk factors, HIV health, substance use, depressive 
symptoms in African-American women with HIV. Consistent with previous research, 
PRD was positively related to the cardiovascular risk factors and to substance use. 
However, it was inversely related to depressive symptoms and viral load. PGD was found 
to negatively relate to cardiovascular risk and substance use but was not significantly 
related to depressive symptoms and viral load. Discrimination-related stress was not 
found to relate to cardiovascular risk factors and substance use, but was significantly 
related to higher depressive symptoms, and when included with PRD and PGD, 
strengthened the inverse associations between PRD and depressive symptoms and viral 
load. 
The physiological pathways investigated in a psychoneuroimmunology 
framework might help future research to better understand the physiological 
underpinnings of the relationship found in the present study. Psychoneuroimmunology 
research investigates the relationships among environmental and psychosocial stress, 
immune functioning, and health (Cohen & Herbert, 1996; Keller, Shiflett, Schleider & 
Bartlett, 1994). Psychosocial experiences such as perceived discrimination and 
discrimination-related stress, and whether these are attributed to external versus internal 
causes, may affect the relations between nervous and endocrine systems and immune 
functioning, which may in tum affect cardiovascular systems, but in ways that are not 
well understood at present. Future research may shed more light on the physiological 
mechanisms underlying these findings. 
HIV Status Group Differences 
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In the present sample, few differences in PRD, PGD, DS, or CC were found 
between women with HIV and at risk for HIV. The infected and uninfected women in the 
sample were matched for socioeconomic status and risk factors for HIV, so they may face 
and perceive similar levels of discrimination. HIV stigma and discrimination did not 
result in HIV-infected women perceiving more discrimination or, alternatively, in 
denying other sources of discrimination, nor to become aware of structural inequality to a 
greater degree than to women at risk for HIV. However, HIV -uninfected women were 
found to differ from infected women on one indicator of critical consciousness, endorsing 
a greater need for social and political change on behalf of African Americans. It is 
unclear why women at risk for HIV would endorse a need for change on behalf of 
African Americans more than HIV -infected women in the context of comparable levels 
of critical consciousness, including similar levels of identification as African-American 
women. Perhaps experiences surrounding the heterosexual transmission of HIV and 
experiences with HIV stigma in HIV-infected women may have lowered their beliefs 
about the possibility of social and political change for African Americans. It is also 
possible that seeing less of a need for social change on behalf of African Americans pre-
dated HIV infection and posed an increased vulnerability to HIV infection. 
There were significant differences between HIV status groups in depressive 
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symptoms and quality of life. Consistent with previous findings, HIV -infected women 
reported higher depressive symptoms (Bhatia et al., 201 0; Ciesla & Roberts, 2001; 
Morrison et al., 2002) and lower quality of life (Miners et al., 2001; Andrinopoulos et al., 
2011) than HIV -uninfected women. Differences between groups in cardiovascular risk 
were not consistently highly statistically or clinically significant. HIV -infected women 
tended to have lower total cholesterol and HDL cholesterol compared to HIV-uninfected 
women, but the groups did not differ in their clinical levels of total cholesterol and HDL 
cholesterol. A higher percentage ofHIV-uninfected women tended to be overweight or 
obese (80%) compared to HIV-infected women (58%). A difference between groups was 
found in substance use. A higher percentage ofHIV-infected women (32%) tended to be 
current or former users of marijuana compared to HIV-uninfected women (14%). 
The differences found in depressive symptoms, quality of life, and marijuana use 
as a function of HIV status may reflect the complex social and health consequences of 
living with HIV. For example, endorsement of more traditional gender roles by HIV-
infected women compared to HIV-uninfected women (Brody et al., 2012) may place 
them at greater risk for depressive symptoms (Jack & Dill, 1992). More traditional 
gender roles have also been associated with marijuana and other illicit substance use, 
particularly among women with HIV (Cruise et al., 2012). The burden ofHIV stigma 
also put HIV-infected women at greater risk for depression and may inhibit support-
seeking and disclosure (Fekete et al., 2009; Mello, Segurado, & Malbergier, 201 0) while 
social and physical aspects of the chronic illness can lower quality of life (Heckman, 
2003). 
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Discrimination, Critical Consciousness, Health, Substance Use, and Incarceration 
Despite the large proportion of African-American women affected by HN and 
incarceration, very little is known about factors related to incarceration in African-
American women with and at risk for HN. Forty-nine percent of the current sample had 
a history of incarceration and this did not differ by HIV status. Older age and 
unemployment were found to relate to a history of incarceration in the current sample. 
After controlling for age, higher PGD and PRD were related to a history of incarceration. 
Greater power discontent and rejection of system legitimacy, aspects of critical 
consciousness, were also associated with greater frequency of incarceration. This 
suggests that experiences with discrimination may contribute to attitudes and behaviors 
that may increase contact with law enforcement. Perhaps increased perceptions of 
injustice may contribute to higher likelihood of behaviors that are actually criminal, or 
that are perceived to have criminal intent by police and other agents of the law (Hagan, 
Shedd, & Payne, 2005). An alternative perspective is that experiences with incarceration 
may contribute to greater awareness of racial and gender discrimination, as incarcerated 
women have had direct experiences with differential and sometimes unjust and 
discriminatory social treatment (Unnever, 2008). In summary, it is possible that the 
ability to perceive social, economic, and political power imbalances and the rejection of 
the system as legitimate is related to behaviors or circumstances that contribute to more 
frequent incarceration; alternatively, the more frequently an individual is incarcerated, the 
more pronounced the sociopolitical inequality becomes. 
Incarceration was also found in the present study to relate to current cannabis use, 
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and current/former (versus no current/former) use of crack, cocaine, or heroin. 
Controlling for PRD, PGD, DS, and CC, current or former marijuana and crack, cocaine, 
or heroin use were significantly related to incarceration. Substance use is common before 
and after incarceration for women, and is a risk factor for both HIV infection and 
incarceration (Kramer & Comfort, 2011). Women are more likely than men to come into 
contact with law enforcement officials for drug use and to serve prison sentences for drug 
related crimes (Conklin, Lincoln, & Tuthill2000; The Sentencing Project, 2007). 
However, the present results also showed that PGD and PRD were significantly related to 
higher likelihood of incarceration when controlling for alcohol and IV drug use. 
Women's use of alcohol illicit drugs may be a form of coping with perceived 
discrimination and stress (Ro & Choi, 2010; Cook et al., 2009). Data from the current 
study showed that the relationship between perceived racial discrimination and higher 
likelihood of incarceration was explained in part by current/former (versus no 
current/former) CCH use. In terms of health outcomes, in the present sample, a history of 
incarceration was significantly related to higher blood pressure. This is consistent with 
the high rates of chronic disease such as hypertension found in prison and jail inmates 
(Wilper et al., 2009). Contextual stressors (e.g., poverty, disordered neighborhoods, 
discrimination) that place individuals at higher risk for higher blood pressure have also 
been found to relate to greater odds of incarceration (Whitaker, Graham, Purr-Holden, 
Milam, & Latimer, 2011). 
In the present sample, a history of incarceration was significantly related to lower 
depressive symptoms. This is in contrast to literature showing that rates of depression are 
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high in incarcerated populations (Scheyett et al. , 201 0). Externalizing behaviors that may 
place individuals at risk for incarceration may substitute for internalizing means of 
coping such as depression. Moreover, for participants who had ever been incarcerated, 
higher critical consciousness was significantly related to lower depressive symptoms, but 
for participants who had never been incarcerated, critical consciousness was not related 
to depressive symptoms. Experience with incarceration may contribute to the 
development of critical consciousness, perhaps through collective experiences with others 
and gaining first-hand information about racial disparities in the prison system, thus 
placing blame for racially disproportionate incarceration on the social system instead of 
the self and buffering against self-directed negative emotions such as depression. 
Study Limitations 
There were several limitations to this study. First, self-report measures of 
discrimination and critical consciousness introduce error from shared method variance, 
social desirability, and the limits of participants' retrospective report. In particular, the 
measures of perceived gender and racial discrimination require participants to reflect 
upon race and gender as independent social attributes, when in daily life, they may be 
integrated parts of social identity. Similarly with the critical consciousness measure, 
items asked about attitudes and beliefs about being female and about being African 
American, which again required the ability to parse aspects of social identity that may be 
difficult to separate. While the Detroit Area Study Questionnaire- Discrimination Scale 
is a widely-used instrument, its attribution and stress scales have been used less 
frequently. However, this measure was used instead of other measures such as the 
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Schedule of Racist Events (SRE; Landrine & Klonoff, 1996) and the Schedule of Sexist 
Events (SSE, Klonoff & Landrine, 1995) because ofWIHS focus group feedback on its 
acceptability among the sample population, including its brevity and reading level. 
Secondly, generalizability of the present study's results is limited to lower income 
African-American women with HIV, and the incarceration findings are limited to women 
at risk for HIV from similar socioeconomic backgrounds. African-American women with 
higher education and income were under-represented in this study. The participants in the 
current study were also recruited from and reside near or in an urban city setting. These 
results may not generalize to low-income African-American women with and at risk for 
HIV in high-risk areas such as the rural South. Because of the small sample size of 
women at risk for HIV, it was not possible to examine the relationships between 
discrimination, critical consciousness, and health and substance use outcomes in this 
population. Thus, these findings cannot be generalized to HIV -uninfected women. 
Finally, the cross-sectional design does not allow for interpretations of causality in the 
relationships found. Causation may be in either direction in the significant relationships 
found or due to factors not examined in the present study. 
Clinical Implications and Future Directions 
The findings from this study have a number of implications for working with 
lower income African-American women with HIV. First, the study results suggest that 
promoting CC in women with HIV can be empowering, promoting better HIV -related 
health in the contexts of perceived racial and gender discrimination and discrimination-
related stress. Particularly for African-American women with and at risk for HIV who 
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have been incarcerated, CC seems to be protective against depressive symptoms. 
However, POD and PRD were associated with incarceration. Second, the results of the 
study indicate that the relationship of gender and racial discrimination to physical and 
psychological health outcomes is extremely complex, with no easily discernible patterns. 
POD and PRD may not be uniformly detrimental to physical and psychological health. 
Attributions of discrimination to gender may protect against cardiovascular risk factors 
and substance use while attributions to race may increase risk for these same variables. 
However, perceived racial discrimination may be protective against depressive symptoms 
in the absence of stress surrounding the discrimination as well viral load in women with 
HIV. Since appraisals of stress related to discrimination contribute to a positive 
relationship between PRD and higher depressive symptoms, it is important to assess for 
appraisal discrimination-related stress when investigating perceptions of discrimination in 
relation to depressive symptoms. 
More research is needed to fully understand how multiple types of perceived 
discrimination impact health and health behaviors, such as the contexts in which 
awareness of discrimination is helpful and when it is harmful. Social psychology research 
indicates that in different social contexts, different aspects of identity (e.g., gender versus 
race versus HIV status) become salient (Howard, 2000), and further research is needed to 
illuminate the social triggers that contribute to identity salience, a topic beyond the scope 
of the present investigation. Emerging research investigating the complex interactions 
among the neuroendocrine, the immune system, and psychosocial factors such as 
discrimination, might help in better understanding the nature of the relationships among 
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discrimination, critical consciousness, and psychological, and physical health outcomes. 
The nature of relationships between perceptions of discrimination and the development of 
critical consciousness as well as their relationships to incarceration also needs to be 
explored more fully. Future work should also examine other major sources of 
discrimination in this population, such as perceived discrimination due to HIV status and 
socioeconomic status. 
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Table 2.1 
Demographic characteristics 
Entire sample HIV+ HIV-
n= 98 n= 73 n=25 
mean (sd) df 
Age 44.9 (9.4) 45.9 (8.3) 41.9 (10.6) -1.86t 96 
xz N 
Education (%) 1.96 98 
Grade 11 or less 44.9 48.0 36.0 
High school completion 32.7 30.1 40.0 
Some or completed college 22.4 21.9 24.0 
Income(%) 4.98 98 
$6,000 or less 37.8 35.6 44.0 
$6,001 - 12,000 29.6 32.9 20.0 
$12,001 -75,000 32.7 31.5 36.0 
Employed 21.4 19.2 28.0 0.86 98 
Marital status 2.27 98 
Married 16.3 16.4 16.0 
Widowed 10.2 11.0 8.0 
Divorced/separated 22.5 24.5 20.0 
Never married 44.9 43.8 48 .0 
Lives with partner/Other 6.1 5.4 8.0 
tp < .10. 
Table 3.1 
Means and Standard Deviations for Entire Sample and by HIV Status for PGD, PRD, 
and CC and T-Test Results for Group Differences 
HIV+ HIV-
Variable Entire sample (n = 73) (n=25) t df 
mean (sd) 
Discrimination Variables 
Perceived racial discrimination 2.19 (.97) 2.22 (.99) 2.10 (.92) 0.28 96 
Perceived gender discrimination 1.96 (.74) 1.99 (.80) 1.86 (.56) 0.07 96 
Discrimination-related stress 2.32 (1.11) 2.31 (1.14) 2.31 (1 .05) -0.03 96 
Critical Consciousness Variables 
Identification 3.47 (.99) 3.43 (.96) 3.58 (1.08) 0.72 96 
Power discontent 4.23 (.49) 4.25 (.52) 4.17 (.41) -0 .76 96 
Rejection of system legitimacy 3.25 (.89) 3.22 (.92) 3.34 (.80) 0.6 96 
BNSC on behalf of women a 3.76 (1.17) 3.67 (1.23) 4.04 (.91) 1.37 94 
BNSC on behalf of AAsa 3.68 (.67) 3.82 (1.09) 4.38 (.71) 2.33* 94 
Collective action orientationb 3.68 (.64) 3.67 (.65) 3.71 (.61) 0.92 93 
Total critical consciousnessb -0 .08 (7 .22) -0 .30 (7.60) 0.56 (6 .03) 0.50 93 
Note. PGD = Perceived gender discrimination, PRD = Perceived racial discrimination, DS = 
Discrimination-related stress, BNSC= Belief in need for social change, AA = African 
American 
8n = 72 (HIV -infected), n =24 (HIV -uninfected), bn = 71 (HIV -infected), n =24 (HIV-
uninfected) 
*p < .05. 
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Table 3.2 
Means and Standard Deviations for Entire Sample and by HIV Status for Continuous 
Outcomes Controlling for Age and Regression Results Testing Group Differences 
Entire sample HIV+ HIV-
(n = 98) (n = 73) (n = 25) 
mean (sd) b p 
Depressive symptoms 13.64 (10 .50) 15.16 (10.89) 9.20 (7.88) 0.24 0.02 
Quality of life 71.72 (20.20) 68.68 (20.91) 80.59 (15.06) -0.22 0.03 
Body mass index 28.82 (8.81) 28.13 (8.52) 30.80 (9.50) .12 n.s . 
Cholesterol 168.62 (41.72) 164.45 (44.28) 180.80 (30.74) -.19 0.07 
HDL cholesterol 54.24 (16 .90) 52.29 (16.64) 59.96 (16.68) -.23 0.02 
Systolic blood pressure 122.96 (20.63) 122.14 (21.56) 125.36 (17.79) -.11 n.s. 
Diastolic blood pressure 77.68 (13.73) 77.34 (14.61) 78.68 (10.92) -.06 n.s . 
Heavy drinking . 67 (.91) .68 (.86) .64 (1.04) 0.03 n.s. 
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Table 3.3 
Frequencies and Percentages of Dichotomous Health Outcome Variables for Entire Sample and 
by HIV Status and Results of Chi-square Tests of Group Differences 
Entire sample HIV -infected HIV -uninfected 
Below Above Below Above Below Above 
(%) (%) (%) (%) (%) (%) xz p 
CES-D 16a 64 (65.3) 34 (34.7) 43 (58.9) 30 (41.1) 21 (84) 4 (16) 4.13 .04 
CES-D 23b 78 (79.6) 20 (20.4) 55 (75.3) 18 (24.7) 23 (92) 2 (8) 2.24 .09 
BMIC 36 (36.7) 62 (63.3) 31 (42.5) 42 (57.5) 5 (20) 20 (80) 3.14 .08 
Cholesterold 78 (79.6) 20 (20.4) 60 (82.2) 13 (17.8) 18 (72) 7 (28) .65 n.s. 
HDL 27 (27.6) 71 (72.4) 23 (31.5) 50 (68.5) 4 (16) 21 (84) 1.53 n.s. 
cholesterole 
Diastolic BPf 75 (76.5) 23 (23.5) 56 (76.7) 17 (23.3) 19 (76) 6 (24) .00 n.s. 
Systolic BPg 78 (79 .6) 20 (20.4) 58 (79.5) 15 (20.5) 20 (80) 5 (20) .00 n.s. 
Note. CES-D = Center for Epidemiological Studies- Depression Scale, BMI =Body Mass 
Index, BP =Blood pressure. •cES- D cut-off= 16, bCES-D cut-off= 23, ccut-off = 25, dcut-off = 
200, ecut-off= 40, fcut-off= 90, gcut-off= 140. 
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Table 3.4 
Frequencies and Percentages of Substance Use Outcome Variables for Entire Sample and by 
HIV Status and Results of Chi-square Tests of Group Differences 
Entire sample HN+ HIV-
No Yes No Yes No Yes 
Variable (%) (%) (%) (%) (%) (%) 2 X p 
Current 
cannabis use 81 (82.7) 17(17.3) 61 (83.6) 12(16.4) 20 (80) 5 (20) 0.01 n.s. 
Current 
crack use 88 (89.8) 10 (10.2) 64 (87.7) 9 (12.3) 24 (96) 1 (4) 0.65 n.s. 
Current 
smoking 40 (40 .8) 58 (59.2) 43 (58 .9) 30 (41.1) 10 (40) 15 (60) 0.00 n.s. 
CIF Never CIF Never CIF Never 
(%) (%) (%) (%) (%) (%) 
Intravenous 
drug use 28 (28.6) 70 (71.4) 24 (32.9) 49 (67.1) 4 (16) 21 (84) 1.84 n.s. 
Cannabis 
use 80 (81.6) 18(18.4) 63 (86.3) 10 (13.7) 17 (68) 8 (32) 3.03 .08 
CCHuse 72 (73.5) 26 (26.5) 55 (75.3) 18 (24.7) 17 (68) 8 (32) 0.21 n.s. 
Alcohol use 33 (33.7) 65 (66.3) 25 {34.2) 48 (65.8) 8 (32) 17 (68) 0.00 n.s. 
Note. CIF = Current/Former; CCH =Crack, cocaine, or heroin. 
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Table 3.5 
Descriptive Statistics for HIV-related Outcome Variables 
for HIV-infected Women 
Variable Frequency Percent N 
ART adherence 65 
>95% of the time 49 75.4 
<95% of the time 16 24.6 
CD4 cell count 73 
<500 cells/mm3 43 58.9 
~00 cells/mm3 30 41.1 
Viral load 73 
<50 copies/mL 36 49.3 
~0 copies/mL 37 50.7 
Mean SD 
Viral load 15903.53 59941.42 
Viral load (loglO) 2.70 1.23 
CD4 cell count 482.52 297.87 
Table 3.6 
Zero-order Correlations among Demographic, Discrimination, and Critical Consciousness 
Variables for HIV-Infected Participants 
Variable 1 2 3 4 5 6 7 8 9 
1. Age -.14 -.07 .21 t .34** .34** .20t .12 .19 
2. Employment .41 *** .24* .02 .04 .05 .00 .21 t 
3. Income .25* -.03 .02 -.10 .01 -.02 
4. Education .03 .15 -.06 -.14 .32** 
5.PGD .89*** .80*** .70*** .36** 
6. PRD .82** .64*** .44*** 
7. DS .69*** .37** 
8.PD .23t 
9.CC 
Note. PGD =Perceived gender discrimination, PRD =Perceived racial discrimination, DS = 
Discrimination stress, PD =Perceived discrimination, CC =Critical consciousness. 
tp < .10. *p < .05. **p < .01. ***p < .001. 
88 
89 
Table 3.7 
Zero-order Correlations between Demographic and Physical Health Outcome Variables 
for HIV-infected Women 
Variable Age Employment Income Education 
HIV-related 
CD4 cell count .25* 0.01 .24* 0.03 
CD4 cell count ;;:500 0.18 0.09 0.17 0.00 
Viral load -0.09 0.2 -0 .15 -0.15 
Viral load (log10) -0.32* -0.04 -0.28* -0.27* 
Viral load ;;:50 -0.24* -0.15 -0.28* -0 .23t 
ART adherence >95%8 0.21 -0 .07 0.10 -0.01 
Cardiovascular risk 
Body mass index -0.06 0.14 0.09 -0.01 
Body mass index ;;:25 0.05 0.14 0.09 -0 .01 
Smoking -0.06 -0.16 -.31 ** -0.03 
Cholesterol 0.02 0.11 .20t -0 .04 
Cholesterol ;;:£00 -0 .08 0.14 0.25* 0.00 
HDL cholesterol 0.04 0.03 0.19 0.14 
HDL cholesterol ~0 0.08 0.11 0.28* 0.12 
Systolic BP 0.12 -0.02 -0.07 0.01 
Systolic BP ~40 0.09 -0.08 -0.03 -0 .06 
Diastolic BP 0.05 -0 .12 -0.15 0.03 
Diastolic BP ;::90 -0.02 -0.10 -0.09 0.04 
Note. BP = Blood pressure. an = 65 . 
tp < .10. *p < .05 . **p < .01. 
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Table 3.8 
Zero-order Correlations between Demographic and Psychological and Substance Use 
Outcome Variables for HIV-infected Women 
Variable Age Employment Income Education 
Psychological 
Depressive symptoms 0.01 0 -0.11 -0. 16 
Depressive symptoms ;;::3. 6 -0.03 0.09 -0.07 -0.06 
Depressive symptoms ;;:2.3 -0.01 0.04 0.03 -0.03 
Quality of life -0.17 0.03 .26* 0.1 8 
Substance use 
Heavy drinking 0.06 0.06 0.07 -0.01 
Intravenous drug use" -.53*** .27* .23* -0.02 
Cannabis use" 0.03 -0.09 0.03 -.34** 
CCHuse" -0. 19 0.13 0.05 0.01 
Alcohol use" 0.02 0.13 0.04 0.07 
Cannabis useb .21 t 0.07 -0.01 0. 12 
Crack useb 0.05 0.03 -0.22 -0 .09 
Note. "current/former v. never use, 6use in past six months, en= 64, an = 71. CCH = Crack, 
cocaine, or heroin. 
tp < .10. *p < .05. **p < .01. ***p < .001. 
Table 3.9 
Partial Correlations between Predictor and Physical Health Outcome Variables, 
Controlling for Age, PD, and Demographics for HIV-Infected Women 
Variable PGD PRD DS cc 
HIV disease progression 
CD4 cell count" 0.11 0.06 .21t .27* 
CD4 cell count ~00 0.03 0.02 0.08 0.06 
Viral load (log 10)b 0.02 -0 .1 0.19 -0.13 
Viral load ~0 -0.06 -0.15 -0.11 -0.06 
ART adherence >95%c 0.11 0.15 0.08 0.08 
Cardiovascular risk factors 
Body mass indexb -0.12 -0.02 0.09 0.06 
Smoking" -0.12 0.05 0.03 -0.02 
Cholesterol (sq rt)b -0.17 -0.04 -0.03 0.00 
Cholesterol :;:::2.00 -0.22 -0 .14 -0.13 -0.17 
HDL cholesterolb -0.02 -0.12 -0.15 0.09 
HDL cholesterol ~Ob -0.02 -0.12 -0.12 -0 .06 
Systolic BPb 0.06 0.25* 0.17 0.01 
Systolic BP ;:i 40 o.2ot 0.26* 0.19 -0.14 
Diastolic BPb -0.05 0.13 0.05 -0 .05 
Diastolic BP ;;::90 0.07 0.23t 0.11 -0.11 
Note. PGD =Perceived gender discrimination, PRD =Perceived racial 
discrimination, DS = Discrimination stress, PD = Perceived discrimination, BP = 
blood pressure. 
"covariates: age, income, and PD, bcovariates: age and PD, en= 65 . 
tp < .10. *p < .05 . **p < .01. ***p < .001. 
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Table 3.10 
Partial Correlations between Predictor and Psychological Health and Substance Use 
Outcome Variables, Controlling for Age, PD, and Demographics for HIV-infected Women 
Variable PGD PRD DS cc 
Psychosocial variables 
Depressive symptoms" -0.13 -.24* 0.09 -.23t 
CES-D 16 -0.11 -0 .18 0.11 -0.27* 
CES-D 23 -0.13 -0.20 -0.06 -0 .21 
Quality of lifeb 0.04 0.09 -0.1 -0.03 
Substance use 
Heavy drinking" 0.00 -0.06 0.09 0.11 
Intravenous drug usee, e 
-0.23t -0.12 -0 .01 0.06 
Cannabis usee -0.13 -0.24* -0 .27* 
-0.12 
CCH use•,e 
-0.08 -0.24* -0 .19 
-0.05 
Alcohol usea,e 
-0.17 -0.05 -0.13 
-0.14 
Current cannabis use"·ct -0.12 -0.05 0.08 0.26* 
Current crack use"·ct -0.03 -0.03 0.16 0.06 
Note. PGD =Perceived gender discrimination, PRD =Perceived racial discrimination, DS 
= Discrimination stress, PD = Perceived discrimination. CCH = Crack, cocaine, or heroin. 
"covariates: age and PD, bcovariates: age, income, and PD, ecurrent/former v. never use, 
ctuse in past six months, •covariates: age, employment, income, & PD. tp < .1 0. *p < .05. 
**p < .01. ***p < .001. 
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Table 3.11 
Summary of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting HIV Viral 
Load Log] 0 in HIV-infected Women 
Model l Model 2 Model3 
Variable E SEE fJ E SEE fJ E SEE 
Constant 2.71 .39 2.94 .42 2.96 .41 
.0 
PD .00 .21 0 .34 .29 .19 .28 .29 
PGD .19 .43 .12 .1 0 .43 
93 
fJ 
.16 
.06 
PRD -.54 .32 -.43t -.72 .35 -.58* 
DS 
R2 
F for R2 change 
.00 
.00 
.1 6 
.52 
.29 
.20 
3.14t 
.23 .27 
Note. PGD = Perceived gender discrimination, PRD = Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
tP < .10. *p < .05 . 
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Table 3.12 
Summary of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting Depressive 
Symptoms in HIV-infected Women 
Modell Model2 Model3 
SE SE 
Variable B SEB f3 B B f3 B B f3 
Constant 10.99 3.14 12.4 3.62 12.81 3.43 
PD 2.39 1.81 0.15 4.55 2.5 .29t 3.42 2.39 0.22 
PGD 2.87 3.72 0.21 0.96 3.57 0.07 
PRD -4 .91 2.8 -.45t -8 .54 2.9 -.77** 
DS 
Ffor R2 
chan e 
0.02 0.08 
1.74 2.13 
5.8 1.92 .61 ** 
0.19 
9.15** 
Note. PGD =Perceived gender discrimination, PRD =Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
tp < .10. *p < .05 . **p < .01. 
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Table 3.13 
Summary of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting Diastolic 
Blood Pressure in HIV-infected Women 
Model l Model 2 Model 3 
Variable B SE E f3 B SE E f3 B SE E f3 
Constant 72.04 4.59 72.71 4.82 72.69 4.86 
PD 3.03 2.43 .15 3.25 3.32 .16 3.32 3.38 0.16 
PGD -1 0.40 4.94 -.57* -10.29 5.06 -.56* 
PRD 8.85 3.72 .60* 9.06 4.11 .61 * 
DS .33 2.71 -.03 
.02 .1 0 .10 
Ffor R2 
change 1.55 2.88t .01 
Note. PGD =Perceived gender discrimination, PRD =Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
tp < .10. *p < .05. 
Table 3.14 
Summary of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting Hypertensive 
Diastolic Blood Pressure in HIV-infected Women 
Modell Mode12 Model3 
Odds Odds Odds 
Variable B SEB ratio B SEB ratio B SEB ratio 
Constant -1.39 1.59 .25 -.84 1.75 .43 -.77 1.75 .47 
Age -.01 .03 .99 -.03 .04 .97 -.03 .04 .97 
PD -1.39 1.59 1.45 .04 .56 1.04 .08 .58 1.08 
PGD -1.10 .84 .33 -1.04 .86 .35 
PRD 1.39* .64 4.02 1.50* .71 4.47 
DS -.77 1.75 -.47 
Note. PGD =Perceived gender discrimination, PRD =Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
*p < .05. 
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Table 3.15 
Summary of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting Systolic Blood 
Pressure in HIV-infected Women 
Modell Model2 Model3 
SE 
Variable B SEB fJ B SEB fJ B B fJ 
Constant 119.26 6.83 117.2 7.04 117.29 7.1 
PD 5.55 3.2 .05 -2.10 4.85 -.07 2.34 4.94 -.08 
PGD -12.72 7.23 -.47t -13.13 7.39 -.48t 
PRD 15.28 5.44 .70** 14.5 6.01 .67* 
DS 1.25 3.97 .07 
.00 .11 .12 
Ffor R2 .21 4.13* .10 
change 
Note. PGD= Perceived gender discrimination, PRD = Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
tp < .10. *p < .05. 
Table 3.1 6 
Summary of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting Cigarette 
Smoking in HIV-infected Women 
Model l Model2 Model 3 
Odds Odds 
Variable E SEE ratio E SE E ratio E SEE 
Constant 1.01 0.79 3.91 1.57 3.35 4.83 1.56 0.86 
Income -.42* 0.17 0.66 .5 1* 7.27 0.60 -0.5 0.1 9 
PD 0.21 0.38 1.23 0.61 1.35 1.83 0.58 0.53 
PGD -1.84* 4.46 0.16 1.91 * 0.89 
PRD 1.1 9t 3.07 3.28 1.09 0.73 
DS 0.17 0.42 
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Odds 
ratio 
4.75 
0.61 
1.78 
0.15 
2.60 
1.19 
Note. PGD= Perceived gender discrimination, PRD = Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
tp < .10. *p < .05. 
99 
Table 3.17 
Summary of Hierarchical Logistic Regression Analysis of PGD, PRD, and DS Predicting 
Cannabis Use in HIV-infected Women 
Modell Model2 Model3 
SE Odds SE Odds SE Odds 
B B ratio B B ratio B B ratio 
Variable 
Constant 5.89 1.02 362.73 6.64 3.54 762.53 7.65 1.11 2106.4 
Education -2.33* 3.15* .10 -2.23* 1.09 .11 -2.53* .07 .08 
PD .06 .84 1.06 .13 2.04 1.14 
PGD 3.05t 1.83 21.18 3.58t 2.06 35.75 
PRD 3.65* 1.83 .03 -3.07 .86 .05 
DS 3.62 .31 
Note. PGD= Perceived gender discrimination, PRD =Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
tp < .10. *p < .05. 
Table 3.18 
Summary of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting Crack, 
Cocaine, or Heroin Use in HIV-infected Women 
Modell Model2 Model3 
Odds Odds SE 
Variable E SEE ratio E SEE ratio E E 
Constant .01 .49 1.01 .24 .64 1.27 .22 .86 
PD -.67 .83 0.51 -.04 1.13 .97 .00 .66 
PGD 1.9t .99 6.72 1.98t 1.14 
PRD -2.45* .86 .09 -2 .31 * 1.04 
DS -.22 .51 
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Odds 
ratio 
1.25 
1.00 
7.21 
.10 
.80 
Note. PGD= Perceived gender discrimination, PRD = Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
tp < .10. *p < .05 . 
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Table 3.19 
Summmy of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting CD4 Cell Count in 
HIV-infected Women 
Model 1 Model 2 Model3 
Variable E SEE fJ E SEE fJ E SEE fJ 
Constant -109.59 195.82 -97.74 200.3 1 -160.36 199.69 
Age 8.44 3.8 .25* 7.26 4.12 .22t 8.53 4.11 .25* 
Income 46.91 20.54 .26* 48.42 20.82 .26* 56 .07 20.87 .31 ** 
PD 53 .35 47.39 .13 10.88 67.52 .03 -5 .62 66.94 -.01 
PGD 90.45 100.38 .24 57.13 100.26 .15 
PRD -30.07 75.29 -.1 0 -98.72 82.78 .33 
DS 100.97 54.66 .39t 
.14 .16 .20 
5. 1 ** .52 3.14t 
change 
Note. PGD= Perceived gender discrimination, PRD = Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
tp < .10. *p < .05. **p < .01. 
Table 3.20 
Summary of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting Clinical 
Depressive Symptoms (CES-D ":;::.16) in HIV-infected Women 
Modell Model2 Model 3 
Odds Odds 
Variable E SEE ratio E SEE ratio E SEE 
Constant -1.64 .62 .19 -1.52 .67 .22 -1.25 0 69 
PD .57 .33 1.78t .84 .45 2.31 t .68 .48 
PGD .45 .66 1.56 .18 .70 
PRD -.67 .49 .51 -1 .27* .58 
DS .98* .39 
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Odds 
ratio 
.22 
1.91 
1.19 
.28 
2.53 
Note. PGD= Perceived gender discrimination, PRD = Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
*p < .05. 
Table 3.21 
Summary of Hierarchical Regression Analysis of PGD, PRD, and DS Predicting Clinical 
Depressive Symptoms (CES-D "223) in HIV-infected Women 
Modell Model2 Model 3 
Odds Odds 
Variable E SEE ratio E SEE ratio E SEE 
Constant -2.03 .69 .13 -1.97 .75 .14 -2.00 . 80 
PD .38 .35 1.46 .52 .48 1.68 .27 .49 
PGD .55 .77 .52 .35 .8 1 
PRD -.65 .58 .52 -1.19t .66 
DS .85* .80 
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Odds 
ratio 
.14 
1.3 1 
1.42 
.31 
2.33 
Note. PGD= Perceived gender discrimination, PRD = Perceived racial discrimination, DS = 
Discrimination stress, PD = Perceived discrimination. 
tp < .10. *p < .05. 
Table 3.22 
Summary of Regression Equations Used in Path Analysis with Depressive 
Symptoms as the Dependent Variable, Controlling/or Age and Perceived 
Discrimination 
R 
Equation Path B ~ se (equation) 
PGD~DS .37 .26t .15 .71 *** 
PRD~Ds .65 .56*** .14 
2 PGD~CES-D .33 .02 .25 .20* 
PRD~ CES-D -9.05 -.82** .25 
DS ~ CES-D 6.11 .64** .19 
Note. PGD= Perceived gender discrimination, PRD = Perceived racial 
discrimination, DS = Discrimination stress, CES-D = Center for 
Epidemiology Studies - Depression Scale. 
tP < .10. *p < .05 . **p < .01. ***p < .001. 
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Table 3.23 
Decomposition of Standardized Effects in Path Analysis with Predictors PGD, 
PRD, and DS and the Outcome Variable CES-D 
Direct Indirect Total 
Predictor Outcome effects effects SE effects 
PGD DS .26 .26 
PRD DS .56 .56 
PGD CES-D .02 .17 .11 .19 
PRD CES-D -.82 .36 .14 -.46 
DS CES-D .64 .64 
Note. PGD= Perceived gender discrimination, PRD =Perceived racial 
discrimination, DS = Discrimination stress, CES-D = Center for Epidemiology 
Studies - Depression Scale. 
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Table 3.24 
Final Model in Regression Analysis of the Interaction of DS and 
CC Predicting CD4 Cell Count in HIV-infected Women 
Variable B SE ~ t 
443.14 35 .79 12.38 
Age 43.98 36.02 0.15 1.22 
Education -18.37 37.3 1 -0 .06 -0.49 
Employment -1.87 35 .37 -0.01 -0.05 
DS 15.95 33.60 0.06 0.48 
cc 13.77 5.86 0.35 2.35* 
DSxCC 12.25 4.47 0.36 2.74** 
Note. DS = Discrimination-related stress, CC = Critical 
consciousness. 
*p < .05. **p < .01. 
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Table 3.25 
Regression Analysis of the interaction of DS and CC Predicting 
Log 1 0-transformed Viral Load in HIV-infected Women 
Variable B SE ~ t 
2.84 0.15 18.92 
Age -0.32 0.16 -0.24 -1.99 
Education -0.27 0.16 -0.22 -1.72 
Employment -0.02 0.15 -0.02 -0.13 
DS 0.04 0.14 0.03 0.27 
cc -0.02 0.02 -0.11 -0.70 
DSxCC -0.04 0.02 -0.26 -2 .03* 
Note. DS = Discrimination-related stress, CC = Critical 
consciousness . 
*p < .05. 
Table 3.26 
Final Model for Regression Analysis of the interaction of DS and 
CC Predicting Clinical CD4 cell count (~00) in HIV-infected 
Women 
Variable B SE 
Constant -.79 .30 
Age .24 .30 
Education -.23 .31 
Employment .15 .31 
DS -.10 .28 
cc .13* .06 
DSxCC .13 * .05 
Note. DS = Discrimination-related stress, CC = Critical 
consciousness . 
*p < .05. 
Exp (B) 
1.27 
.80 
1.16 
.90 
1. 14 
1.14 
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Table 3.27 
Regression Analysis of the interaction of PGD and CC Predicting 
CD4 cell count in HIV-infected Women 
Variable B SE t 
445 .23 33.46 13.31 
Age 62.95 35 .69 0.21 1.76 
Education -26.97 35 .57 -0.09 -0.76 
Employment 11.98 34.31 0.04 0.35 
PGD -3.44 47.23 -0.01 -0.07 
cc 12.25 5.07 0.31 2.42* 
PGD xCC 17.45 4.88 0.41 3.58** 
Note. PGD = Perceived Gender Discrimination, CC = Critical 
consciousness. 
*p < .05 . **p < .01. 
Table 3.28 
Final Model for Regression Analysis of the interaction of PGD 
and CC Predicting Clinical CD4 cell count ( ~00) in HIV-infected 
Women 
Variable B SE Exp (B) 
Constant -.81 .32 .45 
Age .40 .33 1.49 
Education -.27 .31 .76 
Employment .22 .3 1 1.25 
PGD -.29 .44 .75 
cc .12t .06 1.13 
PGD xCC .18** .07 1.20 
Note. PGD = Perceived Gender Discrimination, CC = Critical 
consciousness. 
t < .10. **p < .01. 
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Table 3.29 
Final Model of Regression Analysis of the interaction of PGD and 
CC Predicting Log 1 0-transformed Viral Load in HIV-infected 
Women 
Variable 
Age 
Education 
Employment 
PGD 
cc 
PGDxCC 
B 
2.80 
-.37 
-.27 
-.05 
.02 
-.00 
-.04 
SE 
.15 
.17 
.16 
.15 
.21 
.02 
.02 
19.06 
-.28 -2.24* 
-.21 -1.71 t 
-.04 -.34 
.01 .10 
-.02 -.16 
-.21 
-1.72t 
Note. PGD = Perceived Gender Discrimination, CC = Critical 
consciousness. 
tp < .10. 
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Table 3.30 
Final Model of Regression Analysis of the interaction of PGD and 
CC Predicting Detectable v. Non-detectable Viral Load in HIV-
infected Women 
Variable B SE Exp (B) 
Constant .22 .28 1.24 
Age -.54 .32 .58t 
Education -.44 .31 .64 
Employment -.31 .31 .74 
PGD -.07 .39 .93 
cc -.02 .05 . 98 
PGDxCC -.11 * .05 .90 
Note. PGD = Perceived Gender Discrimination, CC = Critical 
consctousness . 
t < .10. *p < .05. 
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Table3.31 
Final Model of Regression Analysis of the interaction of PRD and 
CC Predicting CD4 cell count on in HIV-infected Women 
Variable B SE ~ t 
432.40 35.35 12.23 
Age 56.79 35 .82 0.19 1.59 
Education -35 .11 35 .66 -0.12 -0 .99 
Employment 0.44 34.62 0.00 0.01 
PRD -24.89 40.49 -0 .08 -0 .62 
cc 14.97 5.51 0.38 2.72** 
PRDxCC 15.61 4.58 0.42 3.41 ** 
Note. PRD =Perceived Racial Discrimination, CC = Critical 
consciousness. 
**p < .01. 
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Table 3.32 
Final Model of Regression Analysis of the interaction of PRD and 
CC Predicting Clinical CD4 cell count (~00) in HIV-infected 
Women 
Variable B SE Exp (B) 
Constant -.91 .34 .40 
Age .35 .32 1.42 
Education -.29 .31 .75 
Employment .12 .31 1.13 
PRD -.43 .38 .65 
cc .13* .06 1.14 
PRDxCC .14* .06 1.16 
Note. PRD = Perceived racial discrimination, CC = Critical 
consciousness. 
*p < .05 . 
Table 3.33 
Final Model of Regression Analysis of the interaction of PRD and 
CC Predicting Detectable v. Non-detectable Viral Load in HIV-
infected Women 
Variable B SE Exp (B) 
Constant .30 .29 1.36 
Age -.45 .31 .64 
Education -.41 .31 .66 
Employment -.27 .32 .77 
PRD -.14 .34 .89 
cc -.03 .05 . 97 
PRDxCC -.11 * .05 .89 
Note. PRD = Perceived Racial Discrimination, CC = Critical 
consciousness. 
tp < .10. *p < .05 . 
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Table 3.34 
Final Model of Regression Analysis of the interaction of DS and 
CAO Predicting Quality of Life in HIV-infected Women 
Variable B SE p t 
69.89 2.39 29.22 
Age -5.99 2.80 -0.27 -2.14 
Education 5.34 2.59 0.25 2.06* 
Employment -1.35 2.59 -0.06 -0.51 
DS -1.85 2.15 -0.10 -0.86 
CAO 0.63 3.78 0.02 0.17 
DSxCAO 8.25 3.20 0.30 2.58* 
Note. DS =Discrimination-related stress, CAO =Collective action 
orientation. 
*p < .05 . 
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Table 3.35 
Regression Analysis of the interaction ofDS and CAO Predicting 
Heavy Drinking in HIV-infected Women 
Variable B SE t 
0.66 0. 10 6.51 
Age 0. 10 0. 12 0.10 0.80 
Education -0.04 0.11 -0.04 -0.35 
Employment 0.05 0.11 0.06 0.45 
DS 0. 12 0.09 0. 16 1.34 
CAO -0.11 0. 16 -0.08 -0.67 
DSxCAO -0.34 0.14 -0.30 -2.46* 
Note. DS = Discrimination-related stress, CAO = Collective action 
orientation. 
*p < .05 . 
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Table 3.36 
Zero-order Correlations of Demographic, CC, and Discrimination Variables and 
Incarceration Variables 
Variable 
Demographics 
Age 
Employment 
Income 
Discrimination 
PGD 
PRD 
DS 
Critical Consciousness 
CC total 
Identification 
Power Discontent 
RSL 
CAO 
Incarceration (yes/no) Incarceration frequency 
(n = 98) (n = 48) 
0.20t 
-0.21 * 
-0 .09 
0.22* 
0.25* 
0.18t 
0.00 
-0.03 
-0.12 
0.16 
0.05 
-0.06 
0.09 
0.07 
0.23 
0.18 
0.18 
0.25t 
0.17 
0.37* 
0.25t 
0.08 
Note. PGD =perceived gender discrimination, PRD =perceived racial 
discrimination, DS = discrimination-related stress, CC = critical consciousness, 
RSL = rejection of system legitimacy, CAO = collective action orientation. tP 
< .10. *p < .05. 
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Table 3.37 
Partial Correlations between Discrimination, CC, and Incarceration Variables 
Variable 
Discriminationa 
PGD 
PRD 
DS 
Critical Consciousnessb 
Identification 
Power Discontent 
RSL 
CAO 
CC total score 
Incarceration (yes/no) 
(n = 98) 
0.18t 
0.22* 
0.17 
-0.02 
-0.12 
0.12 
-0 .04 
-0.02 
Incarceration frequency 
(n = 48) 
0.26t 
0.20 
0.18 
0.16 
0.38* 
0.28t 
-0.07 
0.27t 
Note. PGD = perceived gender discrimination, PRD =perceived racial 
discrimination, DS = discrimination-related stress, CC = critical consciousness, 
RSL =rejection of system legitimacy, CAO =collective action orientation. 
"controlling for age, bcontrolling for age and education. 
tp < .10. *p < .05, 
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Table 3.38 
Partial Correlations between Health and Substance Use and Incarceration 
Variables, Controlling for Age 
Incarceration (yes/no) Incarceration frequency 
Variable 
(n = 98) (n = 48) 
Depressive symptoms -0.21 * -0.17 
Quality of life 0.14 0.13 
Body mass index 0.00 -0.02 
Current smoking 0.09 0.04 
Cholesterol -0.02 -0 .15 
HDL cholesterol -0.01 -0.03 
Systolic blood pressure 0.27** -0.15 
Diastolic blood pressure 0.35*** -0.19 
Heavy drinking -0.21 * 0.18 
Current cannabis use -0.25* 0.25t 
Intravenous drugs" -0.11 -0.14 
Cannabis" 0.02 -0.26t 
Crack/Cocaine/Heroin" -0.52*** -0.13 
Alcohol" 0.09 -0.10 
"current/former versus no current/former use. 
tp < .10. *p < .05 . **p' .01. ***p < .001. 
Table 3.39 
Multiple Regression with Substance Use and Critical Consciousness as 
Predictors of Incarceration, Controlling for Age 
Variable 
Mode/A 
Age 
Crack, cocaine, or heroin 
Critical consciousness 
Constant 
ModelE 
Age 
Cannabis in past 6 months 
Critical consciousness 
Constant 
*p < .05 . ***p < .001. 
B 
0.02 
-3.93*** 
-0 .03 
3.92 
0.05* 
-1.52* 
0.01 
-2.07 
S.E. 
0.03 
1.06 
0.04 
1.88 
0.03 
0.66 
0.03 
1.13 
Exp(B) 
1.02 
0.02 
0.98 
50.57 
1.05 
0.22 
1.01 
0.13 
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Table 3.40 
Multiple Regression with Substance Use and Perceived Gender Discrimination 
(PGD) as Predictors of Incarceration, Controlling for Age 
Variable B S.E. Exp(B) 
Mode/A 
Age 0.01 0.03 1.01 
Crack, cocaine, or heroin -3.72*** 1.06 0.02 
PGD 0.38 0.34 1.46 
Constant 3.29 1.90 26.93 
ModelE 
Age 0.03 0.02 1.03 
Current/former alcohol use 0.70 0.48 2.02 
PGD 0.68* 0.33 1.98 
Constant -3.97 1.46 0.02 
Modele 
Age 0.04 0.02 1.04 
Current/former cannabis use 0.30 0.56 1.35 
PGD 0.57t 0.31 1.77 
Constant -3.07 1.37 0.05 
tP < .10. *p < .05 . ***p < .001. 
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Table 3.41 
Multiple Regression with Substance Use and Perceived Racial Discrimination 
(PRD) as Predictors of Incarceration, Controllingfor Age 
Variable B S.E. Exp(B) 
Model A 
Age 0.01 0.03 1.01 
Crack, cocaine, or heroin -3.66*** 1.06 0.03 
PRD 0.28 0.26 1.32 
Constant 3.26 1.91 26.09 
ModelE 
Age 0.04 0.03 1.04 
Cannabis in past 6 months -1 .69* 0.67 0.18 
PRD 0.57* 0.25 1.77 
Constant -2.78 1.15 0.06 
Model C 
Age 0.03 0 .02 1.03 
Current/former alcohol use 0.68 0.47 1.97 
PRD 0.58* 0.24 1.78 
Constant -3.84 1.41 0.02 
ModelD 
Age 0.03 0.03 1.03 
Current/former intravenous drug use -0.38 0.56 0.68 
PRD 0.46t 0.23 1.59 
Constant -1.53 1.96 0.22 
tp < .10. *p < .05 . ***p < .001. 
Table 3.42 
Final Model of Regression Analysis of the Interaction of CC and 
Incarceration Predicting Depressive Symptoms in HIV- infected 
and Uninfected Women 
Variable 
cc 
Incarceration 
CC x Incarceration 
B 
18.80 
.71 
-3 .64 
-.64 
Note. CC = Critical Consciousness. 
tp < .10. *p < .05. 
SE 
3.23 
.49 
2.04 
.29 
.49 
-.18 
-.74 
29.22 
1.45 
-1.78t 
12.18* 
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PRD 
PG 
Outcome 
Variable 
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Figure 3.1. Predicted model of the relationships among perceived racial discrimination 
(PRD), perceived gender discrimination (PGD), discrimination-related stress (DS), and 
outcome variables. 
PRD~ 
56*:; .64** · **~ DS ____ _. CESD 
PGD 
Figure 3.2. Path analysis model with perceived racial discrimination (PRD) and 
perceived gender discrimination (PGD) predicting discrimination-related stress (DS) and 
depressive symptoms and DS predicting depressive symptoms in HIV -infected women. 
Lighter shaded paths were not significant at p < .05 . 
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Figure 3. 3. Critical consciousness moderating the relationship between 
discrimination-related stress and CD4 cell count. 
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Figure 3. 4. Critical consciousness moderating relationship between 
discrimination-related stress and log 10 transformation of viral load. 
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Figure 3.5. Critical consciousness moderating the relationship between perceived 
gender discrimination and CD4 cell count. 
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Figure 3. 6. Critical consciousness moderating the relationship between perceived 
gender discrimination and viral load (log 1 0-transformed). 
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Figure 3. 8. Critical consciousness moderating the relationship between perceived 
racial discrimination and detectable versus non-detectable viral load. 
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Figure 3.9. Collective action moderating the relationship between discrimination-
related stress and quality of life. 
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Figure 3.11. Depressive symptoms as a function of critical consciousness and 
incarceration history. 
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Figure 3 .12. Clinical levels of depressive symptoms as a function of critical 
consciousness and incarceration history. 
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Figure 3.13. Mediation of perceived racial discrimination and 
incarceration by crack, cocaine, or heroin use. 
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Appendix A: Modified DAS-DQ 
These statements focus on experiences that people sometimes have. When 
answering about how much they happen to you, please think about them in the 
context of different areas of your life. For example, when in public places, when 
with family and friends at home, when at work, and/or when in places where you 
receive healthcare or social services. 
1. You are treated with less courtesy than other people. Has this 
happened .. .. 
1 2 3 4 5 Never/Less than A few times a A few times a At least once a Almost everyday 
once a year year month week 
How much do you think 1 2 3 4 5 your gender had to do with 
this? Nothing A little Some A lot Everything 
How much do you think 1 2 3 4 5 your race/ethnicity had to Nothing A little Some A lot Everything do with this? 
How upset/stressed were 1 2 3 4 5 
you about this treatment? Not at all A little Some Very Extremely 
2. You are treated with less respect than other people. Has this 
happened .... 
1 2 3 4 5 Never/Less than A few times a A few times a At least once a Almost everyday 
once a year year month week 
How much do you think 1 2 3 4 5 your race/ethnicity had to Nothing A little Some A lot Everything do with this? 
How much do you think 1 2 3 4 5 your gender had to do with Nothing A little Some A lot Everything this? 
How upset/stressed were 1 2 3 4 5 
you about this treatment? Not at all A little Some Very Extremely 
3. You receive poorer service than other people at restaurants or 
stores. Has this 
happened .... 
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1 2 3 4 5 Never/Less than A few times a A few times a At least once a 
once a _y_ear year month week Almost everyday 
How much do you think 1 2 3 4 5 your gender had to do with 
this? Nothing A little Some A lot Everything 
How much do you think 1 2 3 4 5 your race/ethnicity had to 
do with this? Nothing A little Some A lot Everything 
How upset/stressed were 1 2 3 4 5 
you about this treatment? Not at all A little Some Very Extremely 
4. People act as if they think you are not smart. Has this happened .... 
1 2 3 4 5 Never/Less than A few times a A few times a At least once a Almost everyday 
once a year year month week 
How much do you think 1 2 3 4 5 your race/ethnicity had to Nothing A little Some A lot Everything do with this? 
How much do you think 1 2 3 4 5 your gender had to do with Nothing A little Some A lot Everything this? 
How upset/stressed were 1 2 3 4 5 
you about this treatment? Not at all A little Some Very Extremely 
5. People act as if they are afraid of you. Has this happened .... 
1 2 3 4 5 Never/Less than A few times a A few times a At least once a Almost everyday 
once a year year month week 
How much do you think 1 2 3 4 5 your gender had to do with 
this? Nothing A little Some Alot Everything 
How much do you think 1 2 3 4 5 your race/ethnicity had to 
do with this? Nothing A little Some A lot Everything 
How upset/stressed were 1 2 3 4 5 
you about this treatment? Not at all A little Some Very Extremely 
6. People act as if they think you are dishonest. Has this happened .... 
1 2 3 4 5 Never/Less than A few times a A few times a At least once a Almost everyday 
once a year y_ear month week 
How much do you think 1 2 3 4 5 your race/ethnicity had to Nothing A little Some A lot Everything do with this? 
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How much do you think 1 2 3 4 5 your gender had to do with 
this? Nothing A little Some A lot Everything 
How upset/stressed were 1 2 3 4 5 
you about this treatment? Not at all A little Some Very Extremely 
7. People act as if you are not as good as they are. Has this 
happened .... 
1 2 3 4 5 Never/Less than A few times a A few times a At least once a Almost everyday 
once a year year month week 
How much do you think 1 2 3 4 5 your gender had to do with 
this? Nothing A little Some Alot Everything 
How much do you think 1 2 3 4 5 your race/ethnicity had to 
do with this? Nothing A little Some Alot Everything 
How upset/stressed were 1 2 3 4 5 
you about this treatment? Not at all A little Some Very Extremely 
8. You are called names or are insulted. Has this happened .... 
1 2 3 4 5 Never/Less than A few times a A few times a At least once a Almost everyday 
once a year year month week 
How much do you think 1 2 3 4 5 your race/ethnicity had to Nothing A little Some A lot Everything do with this? 
How much do you think 1 2 3 4 5 your gender had to do with 
this? Nothing A little Some Alot Everything 
How upset/stressed were 1 2 3 4 5 
you about this treatment? Not at all A little Some Very Extremely 
9. You are threatened or harassed. Has this happened .... 
1 2 3 4 5 Never/Less than A few times a A few times a At least once a Almost everyday 
once a year year month week 
How much do you think 1 2 3 4 5 your gender had to do with 
this? Nothing A little Some A lot Everything 
How much do you think 1 2 3 4 5 your race/ethnicity had to 
do with this? Nothing A little Some A lot Everything 
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How upset/stressed were 1 2 3 4 5 
you about this treatment? Not at all A little Some Very Extremely 
10. How often do people dislike you because of your gender? 
1 2 3 4 5 
Never Rarely Sometimes Often Always 
How upset/stressed were 1 2 3 4 5 
you about this? Not at all A little Some Very Extremely 
11. How often do people dislike you because of your race/ethnicity? 
1 2 3 4 5 
Never Rarely Sometimes Often Always 
How upset/stressed were 1 2 3 4 5 
you about this? Not at all A little Some Very Extremely 
12. How often do people treat you unfairly because of your gender? 
1 2 3 4 5 
Never Rarely Sometimes Often Always 
How upset/stressed were 1 2 3 4 5 
you about this? Not at all A little Some Very Extremely 
13. How often do people treat you unfairly because of your 
race/ethnicity? 
1 2 3 4 5 
Never Rarely Sometimes Often Always 
How upset/stressed were 1 2 3 4 5 
you about this? Not at all A little Some Very Extremely 
14. How often have you seen female friends and family treated 
unfairly because of their gender? 
1 2 3 4 5 
Never Rarely Sometimes Often Always 
How upset/stressed were 1 2 3 4 5 
you about this? Not at all A little Some Very Extremely 
15. How often have you seen African/Black American friends and 
family treated unfairly because or their race/ethnicity? 
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1 2 3 4 5 
Never Rarely Sometimes Often Always 
How upset/stressed were 1 2 3 4 5 
you about this? Not at all A little Some Very Extremely 
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Appendix B: Critical Consciousness Questionnaire 
The next set of survey items asks for your opinion on several more topics related to race 
and gender. There will be slightly different instructions for items as we go through them. 
For some questions, the answer options may seem too simplistic or may not represent 
your opinion but please answer as best as you can and then let me know your ideal 
answer if it is not one of the answer choices given. 
Section 1: 
Some people think that certain groups have too much power and influence in our society 
and that other groups do not have as much as they deserve. I am going to read a list of a 
few groups in society. Please tell me whether you think each of the groups have too little 
power, just the right amount of power, or too much power using the scale in front of you, 
where 1 = too little, and 5 = too much, power. 
Too Just Too 
little right much 
1 Women 1 2 3 4 5 
2 Men 1 2 3 4 5 
3 African/Black Americans 1 2 3 4 5 
4 People of other races 1 2 3 4 5 
5 Poor people 1 2 3 4 5 
6 Rich people 1 2 3 4 5 
Section II: 
Please answer the next two questions about identification with the 5-point scale, where 1 
= "not at all" and 5 ="completely." 
1 How much do you identify with other women? 
In other words, how much do you think you 
have in common with women? 
2 How much do you identify as an African/Black 
American? In other words, how much do you 
th ink you have in common with African/Black 
Americans? 
Not at A 
all little 
1 2 
1 2 
Some A lot Complete! 
y 
3 4 5 
3 4 5 
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Section Ill: 
The next few questions each consist of 2 statements containing different opinions about 
a topic. Please think about and tell me how much you agree with each statement on a 
scale of 1 to 5 with 1 = "not agree at all" and 5 = "completely agree". 
1a African/Black American women get HIV because they are irresponsible. 
How much do you agree 1 2 3 4 5 
with this statement? Not at all A little Somewhat Very much Completely 
1 b African/Black American women get HIV for a number of reasons, including less 
access to healthcare information and other resources and a higher rate of HIV in 
the community. 
How much do you agree 1 2 3 4 5 
with this statement? Not at all A little Somewhat Very much Completely 
2a African/Black Americans deserve to be included in affirmative action policies for 
employment and for college admissions. 
How much do you agree 1 2 3 4 5 
with this statement? Not at all A little Somewhat Very much Completely 
2b African/Black Americans should compete with people of other races for 
employment and college admissions without affirmative action. 
How much do you agree 1 2 3 4 5 
with this statement? Not at all A little Somewhat Very much Completely 
3a Many African/Black Americans can't seem to get ahead because they don't try 
as hard as people of other races. 
How much do you agree 1 2 3 4 5 
with this statement? Not at all A little Somewhat Very much Completely 
3b Many African/Black Americans can't seem to get ahead because they have a 
harder time working within a biased system. 
How much do you agree 1 2 3 4 5 
with this statement? Not at all A little Somewhat Very much Completely 
4a More African/Black Americans are in prison because the legal system has 
different standards for different races. 
How much do you agree 1 2 3 4 5 
with this statement? Not at all A little Somewhat Very much Completely 
4b More African/Black Americans are in prison because they commit more crimes 
than people of other races. 
How much do you agree 1 2 3 4 5 
with this statement? Not at all A little Somewhat Very much Completely 
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Section IV: 
This next section asks about your beliefs about social and political change. Social and 
political change refers to changes in society (e.g., on the community, state, and national 
levels) that make life better and things fairer for people. 
Not at A Some A lot Very 
all little much 
How much do you think that political and 1 2 3 4 5 
social change is necessary for women of 
all races (e.g., Black, White, Latina, Asia1 
etc.)? 
How much do you think that political and 1 2 3 4 5 
social change is necessary 
for African/Black American men and 
women? 
Please rank order from 1 to 6 what you think are the best ways for women of all races 
to take action to bring about political and social change, with 1 being the best way. (You 
do not have to be doing any of these yourself). 
__ Contacting political leaders (e.g., calling or writing to them) 
__ Joining or organizing people in the community to work together 
__ Voting in local and national elections 
__ Participating in rallies or marches to gain public attention and educate about the 
issues 
__ Talking to people in the community individually (e.g., to family, friends, 
neighbors) 
__ Being active in a church group or organization 
Please rank order from 1 to 6 what you think are the best ways for African/Black 
American men and women to take action to bring about political and social change, 
with 1 being the best way. (You do not have to be doing any of these yourself). 
__ Contacting political leaders (e.g., calling or writing to them) 
__ Joining or organizing a community group to work together 
__ Voting in local and national elections 
__ Participating in rallies or marches to gain public attention and educate about the 
issues 
__ Talking to people in the community individually (e.g., to family, friends, 
neighbors) 
__ Being active in a church group or organization 
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